Global Gas (HGAS) 10-K/A 17 Jul 23 2022 FY Annual report (amended) Financial data

Document And Entity Information

Document And Entity Information - USD ($)	12 Months Ended
	Dec. 31, 2022	Apr. 07, 2023	Jun. 30, 2022
Document Information Line Items
Entity Registrant Name	Dune Acquisition Corp
Trading Symbol	DUNE
Document Type	10-K/A
Current Fiscal Year End Date	--12-31
Entity Public Float			$ 11,610,961.83
Amendment Flag	true
Amendment Description	Dune Acquisition Corporation (the “Company,” “we,” “our” or “us”) is filing this Amendment No. 1 to its Annual Report on Form 10-K/A (the “Amendment”) to amend its Annual Report on Form 10-K for the fiscal year ended December 31, 2022, originally filed with the Securities and Exchange Commission (the “SEC”) on April 10, 2023 (the “Original Filing”), for the purpose of restating the net income in its Consolidated Statements of Changes in Stockholders’ Deficit for the years ended December 31, 2022 and 2021 that was incorrectly reported due to a clerical error. This clerical error has been corrected in this Amendment. In accordance with SEC Staff Accounting Bulletin No. 99, Materiality, and SEC Staff Accounting Bulletin No. 108, Considering the Effects of Prior Year Misstatements when Quantifying Misstatements in Current Year Financial Statements, the Company evaluated such error and has determined that the related impacts were material.Pursuant to Rule 12b-15 promulgated under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), this Amendment also contains new certifications by our chief executive officer and chief financial officer.Except as described above, this Amendment does not amend, update or change any other items or disclosures contained in the Original Filing, and accordingly, this Amendment does not reflect or purport to reflect any information or events occurring after the original filing date or modify or update those disclosures affected by subsequent events. Accordingly, this Amendment should be read in conjunction with the Original Filing and the Company’s other filings with the SEC.
Entity Central Index Key	0001817232
Entity Current Reporting Status	Yes
Entity Voluntary Filers	No
Entity Filer Category	Non-accelerated Filer
Entity Well-known Seasoned Issuer	No
Document Period End Date	Dec. 31, 2022
Document Fiscal Year Focus	2022
Document Fiscal Period Focus	FY
Entity Small Business	true
Entity Emerging Growth Company	true
Entity Shell Company	true
Entity Ex Transition Period	false
ICFR Auditor Attestation Flag	false
Document Annual Report	true
Document Transition Report	false
Entity File Number	001-39819
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	85-1617911
Entity Address, Address Line One	700 S. Rosemary Avenue
Entity Address, Address Line Two	Suite 204
Entity Address, City or Town	West Palm Beach
Entity Address, State or Province	FL
Entity Address, Postal Zip Code	33401
City Area Code	1 (917)
Local Phone Number	742-1904
Title of 12(b) Security	Class A common stock, par value $0.0001 per share
Security Exchange Name	NASDAQ
Entity Interactive Data Current	Yes
Auditor Name	WithumSmith+Brown, PC
Auditor Location	New York
Auditor Firm ID	100
Class A Common Stock
Document Information Line Items
Entity Common Stock, Shares Outstanding		1,182,054
Class B Common Stock
Document Information Line Items
Entity Common Stock, Shares Outstanding		4,312,500

Consolidated Balance Sheets

Consolidated Balance Sheets - USD ($)	Dec. 31, 2022	Dec. 31, 2021
Current assets:
Cash	$ 313	$ 116,140
Prepaid expenses		92,473
Receivable from settlement	2,750,000
Total current assets	2,750,313	208,613
Cash and investments held in Trust Account	11,970,547	172,543,076
Total Assets	14,720,860	172,751,689
Current liabilities:
Accounts payable	1,864,900	131,853
Accrued expenses	2,602,327	1,598,232
Due to related party	1,500	30,811
Franchise tax payable	216,250	160,097
Income tax payable	78,561
Total current liabilities	4,763,538	1,920,993
Deferred underwriting commissions		6,037,500
Derivative warrant liabilities	134,750	6,602,750
Total liabilities	4,898,288	14,561,243
Commitments and Contingencies
Class A common stock subject to possible redemption, $0.0001 par value; 1,182,054 and 17,250,000 shares issued and outstanding at $10.00 per share at redemption as of December 31, 2022 and 2021, respectively	11,820,540	172,500,000
Stockholders’ Deficit:
Preferred stock, $0.0001 par value; 1,000,000 shares authorized; no shares issued or outstanding as of December 31, 2022 and 2021
Class A common stock, $0.0001 par value; 380,000,000 shares authorized; no non-redeemable shares issued or outstanding as of December 31, 2022 and 2021
Class B common stock, $0.0001 par value; 20,000,000 shares authorized; 4,312,500 shares issued and outstanding as of December 31, 2022 and 2021	431	431
Additional paid-in capital
Accumulated deficit	(1,998,399)	(14,309,985)
Total stockholders’ deficit	(1,997,968)	(14,309,554)
Total Liabilities, Class A Common Stock Subject to Possible Redemption and Stockholders’ Deficit	$ 14,720,860	$ 172,751,689

Consolidated Balance Sheets (Pa

Consolidated Balance Sheets (Parentheticals) - $ / shares	Dec. 31, 2022	Dec. 31, 2021
Preferred stock, par value (in Dollars per share)	$ 0.0001	$ 0.0001
Preferred stock, shares authorized	1,000,000	1,000,000
Preferred stock, shares issued
Preferred stock, shares outstanding
Class A Common Stock
Common stock shares subject to possible redemption per share	10	10
Common stock subject to possible redemption shares issued	1,182,054	17,250,000
Common stock subject to possible redemption shares outstanding	1,182,054	17,250,000
Common stock subject to possible redemption par value (in Dollars per share)	$ 0.0001	$ 0.0001
Common stock, par value (in Dollars per share)	$ 0.0001	$ 0.0001
Common stock, shares authorized	380,000,000	380,000,000
Non-redeemable shares issued
Non-redeemable shares outstanding
Class B Common Stock
Common stock, par value (in Dollars per share)	$ 0.0001	$ 0.0001
Common stock, shares authorized	20,000,000	20,000,000
Common stock, shares issued	4,312,500	4,312,500
Common stock, shares outstanding	4,312,500	4,312,500

Consolidated Statements of Oper

Consolidated Statements of Operations - USD ($)	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
General and administrative expenses	$ 2,882,820	$ 2,215,708
General and administrative expenses - related party	120,000	120,000
Franchise tax expense	225,903	204,258
Total operating expenses	(3,228,723)	(2,539,966)
Other income (expenses):
Change in fair value of derivative warrant liabilities	6,468,000	7,977,860
Gain from extinguishment of deferred underwriting commissions allocated to derivative warrant liabilities	287,989
Gain on settlement	2,750,000
Interest earned on operating account	4
Income on investments held in Trust Account	363,366	110,381
Income before income tax expense	6,640,636	5,548,275
Provision for income tax	78,561
Net income	$ 6,562,075	$ 5,548,275
Class A Common Stock
Other income (expenses):
Weighted average shares outstanding, basic and diluted (in Shares)	8,709,777	17,250,000
Basic and diluted net income per share (in Dollars per share)	$ 0.5	$ 0.26
Class B Common Stock
Other income (expenses):
Weighted average shares outstanding, basic and diluted (in Shares)	4,312,500	4,312,500
Basic and diluted net income per share (in Dollars per share)	$ 0.5	$ 0.26

Consolidated Statements of Op_2

Consolidated Statements of Operations (Parentheticals) - $ / shares	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Class A Common Stock
Weighted average shares outstanding, basic and diluted	8,709,777	17,250,000
Basic and diluted net income per share	$ 0.50	$ 0.26
Class B Common Stock
Weighted average shares outstanding, basic and diluted	4,312,500	4,312,500
Basic and diluted net income per share	$ 0.50	$ 0.26

Consolidated Statements of Chan

Consolidated Statements of Changes in Stockholders’ Deficit - USD ($)	Class A Common Stock	Class B Common Stock	Additional Paid-In Capital	Accumulated Deficit	Total
Balance at Dec. 31, 2020		$ 431		$ (19,858,260)	$ (19,857,829)
Balance (in Shares) at Dec. 31, 2020		4,312,500
Net income				5,548,275	5,548,275
Balance at Dec. 31, 2021		$ 431		(14,309,985)	(14,309,554)
Balance (in Shares) at Dec. 31, 2021		4,312,500
Net income				6,562,075	6,562,075
Adjustment for accretion of Class A common stock subject to possible redemption amount – accumulated deficit				5,749,511	5,749,511
Balance at Dec. 31, 2022		$ 431		$ (1,998,399)	$ (1,997,968)
Balance (in Shares) at Dec. 31, 2022		4,312,500

Consolidated Statements of Cash

Consolidated Statements of Cash Flows - USD ($)	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Cash Flows from Operating Activities:
Net income	$ 6,562,075	$ 5,548,275
Adjustments to reconcile net income to net cash used in operating activities:
Change in fair value of derivative warrant liabilities	(6,468,000)	(7,977,860)
Gain on settlement of deferred underwriting commission	(287,989)
Income on investments held in Trust Account	(363,366)	(110,381)
Changes in operating assets and liabilities:
Prepaid expenses	92,473	224,516
Receivable from settlement	(2,750,000)
Accounts payable	1,733,047	(200,410)
Accrued expenses	1,074,095	1,528,232
Due to related party	(29,311)	30,811
Franchise tax payable	56,153	53,198
Income tax payable	78,561
Net cash used in operating activities	(302,262)	(903,619)
Cash Flows from Investing Activities
Investment income released from Trust Account to pay for franchise taxes	256,435	78,517
Withdrawal for redemption payment	160,679,460
Net cash provided by investing activities	160,935,895	78,517
Cash Flows from Financing Activities:
Offering costs paid	(70,000)
Payment of Class A common stock subject to possible redemption	(160,679,460)
Net cash used in financing activities	(160,749,460)
Net change in cash	(115,827)	(825,102)
Cash - beginning of the period	116,140	941,242
Cash - end of the period	313	$ 116,140
Supplemental disclosure of noncash financing activities
Extinguishment of deferred underwriting commissions allocated to Public Shares	$ 5,749,511

Description of Organization and

Description of Organization and Business Operations	12 Months Ended
	Dec. 31, 2022
Description of Organization and Business Operations [Abstract]
Description of Organization and Business Operations	Note 1. Description of Organization and Business Operations Organization and General Dune Acquisition Corporation (the “Company”) is a blank check company incorporated in Delaware on June 18, 2020. The Company was formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses (the “business combination”). The Company is an emerging growth company and, as such, the Company is subject to all of the risks associated with emerging growth companies. As of December 31, 2022, the Company had not commenced any operations. All activity for the period from June 18, 2020 (inception) through December 31, 2022 relates to the Company’s formation and the initial public offering (the “initial public offering”), described below, and since the closing of the initial public offering, the search for a prospective initial business combination. The Company will not generate any operating revenues until after the completion of its initial business combination, at the earliest. The Company will generate non-operating income in the form of interest income from the proceeds derived from the initial public offering (as defined below). Sponsor and Financing The Company’s sponsor is Dune Acquisition Holdings LLC, a Delaware limited liability company (the “Sponsor”). The registration statement for the Company’s initial public offering was declared effective on December 17, 2020. On December 22, 2020, the Company consummated its initial public offering of 17,250,000 units (the “units”) and, with respect to the Class A common stock included in the units being offered, (the “public shares”), including 2,250,000 additional units to cover over-allotments (the “Over-Allotment Units”), at $10.00 per unit, generating gross proceeds of $172.5 million, and incurring offering costs of approximately $10.0 million, of which approximately $6.0 million was for deferred underwriting commissions (Note 6). Simultaneously with the closing of the initial public offering, the Company consummated the private placement (“private placement”) of 4,850,000 warrants (each, a “private placement warrant” and collectively, the “private placement warrants”) at a price of $1.00 per private placement warrant to the Sponsor, generating proceeds of approximately $4.9 million (Note 5). Trust Account Upon the closing of the initial public offering and the private placement, $172.5 million ($10.00 per Unit) of the net proceeds of the initial public offering and certain of the proceeds of the private placement was held in a trust account (the “trust account”) located in the United States with Continental Stock Transfer & Trust Company acting as trustee, and invested only in U.S. “government securities” within the meaning of Section 2(a)(16) of the Investment Company Act 1940, as amended (the “Investment Company Act”) having a maturity of 185 days or less or in money market funds meeting certain conditions under Rule 2a-7 promulgated under the Investment Company Act which invest only in direct U.S. government treasury obligations, as determined by the Company, until the earlier of: (i) the completion of a business combination and (ii) the distribution of the trust account as described below. On December 15, 2022, to mitigate the risk of us being deemed to have been operating as an unregistered investment company under the Investment Company Act, the Company instructed Continental Stock Transfer & Trust Company, the trustee with respect to the trust account, to liquidate the U.S. government treasury obligations or money market funds held in the trust account and thereafter to hold all funds in the trust account in cash (i.e., in one or more interest-bearing demand deposit accounts) until the earlier of the consummation of a business combination or our liquidation. As of December 31, 2022, the funds in the trust account are held solely in an interest-bearing demand deposit account. June 2022 Extension Special Meeting of Stockholders On June 14, 2022, the Company held a special meeting of stockholders (the “Special Meeting”). At the Special Meeting, the Company’s stockholders approved an amendment to the Company’s Amended and Restated Certificate of Incorporation (the “Charter Amendment”) to extend the date by which the Company must complete a business combination from June 22, 2022 to December 22, 2023. In connection with the Special Meeting, stockholders holding 16,409,033 public shares exercised their right to redeem such shares for a pro rata portion of the funds held in the trust account, which would have resulted in (i) approximately $164.1 million (approximately $10.00 per share) being removed from the trust account to pay such holders, (ii) approximately $8.4 million remaining in the trust account and (iii) 5,153,467 shares of common stock outstanding (including 840,967 public shares and 4,312,500 Founder Shares (as defined in Note 5)). On June 15 and 16, 2022, the Company consented to requests to reverse the redemptions of an aggregate of 341,087 public shares. As a result of such redemption reversals, (i) stockholders holding an aggregate of 16,067,946 public shares exercised and have not reversed their right to redeem such shares for a pro rata portion of the funds held in the trust account, (ii) approximately $160.7 million (approximately $10.00 per share) was removed from the trust account to pay such holders, (iii) approximately $11.8 million remained in the trust account and (iv) 5,494,554 shares of common stock remained outstanding (including 1,182,054 public shares and 4,312,500 Founder Shares). Initial Business Combination The Company’s management has broad discretion with respect to the specific application of the net proceeds of the initial public offering and the sale of private placement warrants, although substantially all of the net proceeds are intended to be applied generally toward consummating a business combination. There is no assurance that the Company will be able to complete a business combination successfully. The Company must complete one or more initial Business Combinations having an aggregate fair market value of at least 80% of the net assets held in the trust account (excluding the deferred underwriting commissions and taxes payable on the interest earned on the trust account) at the time of signing a definitive agreement in connection with the initial business combination. However, the Company will only complete a business combination if the post-transaction company owns or acquires 50% or more of the voting securities of the target or otherwise acquires a controlling interest in the target sufficient for it not to be required to register as an investment company under the Investment Company Act. The Company will provide the holders (the “public stockholders”) of the public shares with the opportunity to redeem all or a portion of their public shares upon the completion of a business combination either (i) in connection with a stockholder meeting called to approve the business combination or (ii) by means of a tender offer. The decision as to whether the Company will seek stockholder approval of a business combination or conduct a tender offer will be made by the Company, solely in its discretion. The public stockholders will be entitled to redeem their public shares for a pro rata portion of the amount then held in the trust account (initially anticipated to be $10.00 per public share). The per-share amount to be distributed to public stockholders who redeem their public shares will not be reduced by the deferred underwriting commissions the Company will pay to the underwriters (as discussed in Note 6). These public shares are recorded at a redemption value and classified as temporary equity in accordance with the Financial Accounting Standards Board’s (“FASB”) Accounting Standards Codification (“ASC”) Topic 480 “Distinguishing Liabilities from Equity.” The Company will proceed with a business combination if a majority of the shares voted are voted in favor of the business combination. The Company will not redeem the public shares in an amount that would cause its net tangible assets to be less than $5,000,001. If a stockholder vote is not required by law and the Company does not decide to hold a stockholder vote for business or other legal reasons, the Company will, pursuant to its Certificate of Incorporation (the “Certificate of Incorporation”), conduct the redemptions pursuant to the tender offer rules of the U.S. Securities and Exchange Commission (“SEC”) and file tender offer documents with the SEC prior to completing a business combination. If, however, stockholder approval of the transaction is required by law, or the Company decides to obtain stockholder approval for business or legal reasons, the Company will offer to redeem shares in conjunction with a proxy solicitation pursuant to the proxy rules and not pursuant to the tender offer rules. Additionally, each public stockholders may elect to redeem their public shares irrespective of whether they vote for or against the proposed transaction. If the Company seeks stockholder approval in connection with a business combination, the initial stockholders (as defined below) agreed to vote their Founder Shares (as defined below in Note 5) and any public shares purchased during or after the initial public offering in favor of a business combination. In addition, the initial stockholders agreed to waive their redemption rights with respect to their Founder Shares and public shares in connection with the completion of a business combination. The Certificate of Incorporation provides that a public stockholder, together with any affiliate of such stockholder or any other person with whom such stockholder is acting in concert or as a “group” (as defined under Section 13 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)), will be restricted from redeeming its shares with respect to more than an aggregate of 20% or more of the public shares, without the prior consent of the Company. The Sponsor and the Company’s officers and directors (the “initial stockholders”) agreed not to propose an amendment to the Certificate of Incorporation to modify the substance or timing of the Company’s obligation to redeem 100% of the public shares if the Company does not complete a business combination within the Combination Period (as defined below) or with respect to any other material provisions relating to stockholders’ rights or pre-initial business combination activity, unless the Company provides the public stockholders with the opportunity to redeem their public shares in conjunction with any such amendment. If the Company is unable to complete a business combination within 36 months from the closing of the initial public offering, or December 22, 2023 (the “Combination Period”), the Company will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than ten business days thereafter, redeem the public shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the trust account, including interest earned on the funds held in the trust account and not previously released to the Company to pay its taxes (less up to $100,000 of interest to pay dissolution expenses), divided by the number of then outstanding public shares, which redemption will completely extinguish public stockholders’ rights as stockholders (including the right to receive further liquidating distributions, if any), and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the remaining stockholders and the board of directors, liquidate and dissolve, subject, in each case, to the Company’s obligations under Delaware law to provide for claims of creditors and the requirements of other applicable law. The initial stockholders agreed to waive their rights to liquidating distributions from the trust account with respect to the Founder Shares if the Company fails to complete a business combination within the Combination Period. However, if the initial stockholders acquire public shares in or after the initial public offering, they will be entitled to liquidating distributions from the trust account with respect to such public shares if the Company fails to complete a business combination within the Combination Period. The underwriters agreed to waive their rights to the deferred underwriting commission (see Note 6) held in the trust account in the event the Company does not complete a Business Combination within the Combination Period and, in such event, such amounts will be included with the other funds held in the trust account that will be available to fund the redemption of the public shares. In the event of such distribution, it is possible that the per share value of the residual assets remaining available for distribution (including trust account assets) will be only $10.00. In order to protect the amounts held in the trust account, the Sponsor has agreed to be liable to the Company if and to the extent any claims by a third party (except for the Company’s independent registered public accounting firm) for services rendered or products sold to the Company, or a prospective target business with which the Company has entered into a letter of intent, confidentiality or other similar agreement or Business Combination agreement (a “Target”), reduce the amount of funds in the trust account to below the lesser of (i) $10.00 per public share and (ii) the actual amount per public share held in the trust account as of the date of the liquidation of the trust account, if less than $10.00 per public shares due to reductions in the value of the trust assets, less taxes payable, provided that such liability will not apply to any claims by a third party or Target that executed a waiver of any and all rights to the monies held in the trust account (whether or not such waiver is enforceable) nor will it apply to any claims under the Company’s indemnity of the underwriters of the initial public offering against certain liabilities, including liabilities under the Securities Act of 1933, as amended (the “Securities Act”). The Company will seek to reduce the possibility that the Sponsor will have to indemnify the trust account due to claims of creditors by endeavoring to have all vendors, service providers, except for the Company’s independent registered public accounting firm, prospective target businesses or other entities with which the Company does business, execute agreements with the Company waiving any right, title, interest or claim of any kind in or to monies held in the trust account. Proposed Business Combination On October 12, 2021, the Company entered into an Agreement and Plan of Merger (the “Merger Agreement”), by and among the Company, Dune Merger Sub, Inc., a Delaware corporation and a direct wholly-owned subsidiary of the Company (“Merger Sub”), Dune Merger Sub II, LLC, a Delaware limited liability company and direct, wholly-owned subsidiary the Company (“Merger Sub II”), and TradeZero Holding Corp., a Delaware corporation (“TradeZero”). Dispute Relating to the Business Combination with TradeZero On April 1, 2022, the Company, along with Merger Sub, Merger Sub II and the Sponsor (collectively, the “Dune Plaintiffs”) filed a four-count complaint in the Delaware Court of Chancery against TradeZero and Messrs. Pipitone, Ferrara, Muscatella, Choi, Koslow, Caruso and Corriveau (together, the “TradeZero Defendants”), each of whom are part of TradeZero’s management team. The Dune Plaintiffs asserted claims for breach of contract, fraudulent inducement, fraudulent misrepresentation and unjust enrichment against the TradeZero Defendants. On May 3, 2022, after careful consideration and consultation with the Company’s management and outside legal advisors, the Company’s board of directors (the “Board”), who had previously unanimously endorsed and approved of the business combination with TradeZero, announced that it had changed its recommendation to the Company’s stockholders and then unanimously recommended that the Company’s stockholders vote against the business combination with TradeZero. On May 5, 2022, the TradeZero Defendants filed a motion to dismiss the Dune Plaintiffs’ lawsuit; on July 8, 2022, the Company filed an amended complaint; and on July 22, 2022 TradeZero filed a motion to dismiss the amended complaint. On July 13, 2022, the Company received a notice from TradeZero that purported to terminate the Merger Agreement pursuant to Sections 10.01(c) and 10.01(i) thereof (the “Purported Termination Notice”). On July 15, 2022, the Company sent a letter to TradeZero in response to the Purported Termination Notice stating, among other things, that TradeZero is not permitted to terminate the Merger Agreement because of TradeZero’s breaches of, and failure to perform under, the Merger Agreement. On December 28, 2022, the Dune Plaintiffs entered into a Settlement Agreement and Release (the “Settlement Agreement”) with the TradeZero Defendants, pursuant to which (i) the Company and TradeZero mutually agreed to terminate the Merger Agreement and (ii) the Dune Plaintiffs and the TradeZero Defendants agreed to a mutual release of all claims related to the Merger Agreement, the transactions contemplated thereby, and the lawsuit filed by the Dune Plaintiffs against TradeZero Defendants in the Delaware Court of Chancery, in each case effective upon receipt in full by the Dune Plaintiffs from the insurers of the TradeZero Defendants of $5,000,000 in settlement consideration within 15 business days of the date of the Settlement Agreement. For additional information regarding the Merger Agreement and the Settlement Agreement, see the Company’s Current Reports on Form 8-K filed with the Securities and Exchange Commission (the “SEC”) on October 12, 2021, January 26, 2022, July 15, 2022 and December 30, 2022 and the Company’s preliminary proxy statement (as amended), initially filed with the SEC on January 26, 2022. Liquidity and Going Concern As of December 31, 2022, the Company had approximately $300 in cash in its operating account and working capital of approximately $1.7 million (excluding tax obligations of approximately $295,000 that may be paid using investment income earned from the trust account). The Company’s liquidity needs prior to the consummation of the initial public offering were satisfied through the payment of $25,000 from the Sponsor to purchase Founders Shares (as defined in Note 5), and loan proceeds from the Sponsor of approximately $31,000 under the Note (Note 5). The Company repaid the loan in full on December 22, 2020. Subsequent from the consummation of the initial public offering, the Company’s liquidity has been satisfied through the net proceeds from the consummation of the initial public offering and the private placement held outside of the trust account. In addition, the Company’s portion of the settlement of lawsuit in the amount of $2.75 million was received in January 2023. In connection with the Company’s assessment of going concern considerations in accordance with FASB Accounting Standards Update (“ASU”) 2014-15, “Disclosures of Uncertainties about an Entity’s Ability to Continue as a Going Concern,” the Company has until December 22, 2023 to consummate a business combination. It is uncertain that the Company will be able to consummate a business combination by this time. Management has determined that the liquidity position, mandatory liquidation and subsequent dissolution raises substantial doubt about the Company’s ability to continue as a going concern. Management intends to complete the business combination prior to the liquidation date. No adjustments have been made to the carrying amounts of assets or liabilities should the Company be required to liquidate after December 22, 2023. The Company intends to complete a proposed business combination before the mandatory liquidation date. However, there can be no assurance that the Company will be able to consummate any business combination by December 22, 2023. Risks and Uncertainties Management continues to evaluate the impact of the COVID-19 pandemic and has concluded that while it is reasonably possible that the virus could have a negative effect on the Company’s, or its target’s, financial position, results of its operations and/or completion of the business combination, the specific impact is not readily determinable as of the date of these consolidated financial statements. The consolidated financial statements do not include any adjustments that might result from the outcome of this uncertainty. In February 2022, the Russian Federation and Belarus commenced a military action with the country of Ukraine. As a result of this action, various nations, including the United States, have instituted economic sanctions against the Russian Federation and Belarus. Further, the impact of this action and related sanctions on the world economy are not determinable as of the date of these financial statements and the specific impact on the Company’s financial condition, results of operations, and cash flows is also not determinable as of the date of these financial statements. On August 16, 2022, the Inflation Reduction Act of 2022 (the “IR Act”) was signed into federal law. The IR Act provides for, among other things, a new U.S. federal 1% excise tax on certain repurchases of stock by publicly traded U.S. domestic corporations and certain U.S. domestic subsidiaries of publicly traded foreign corporations occurring on or after January 1, 2023. The excise tax is imposed on the repurchasing corporation itself, not its shareholders from which shares are repurchased. The amount of the excise tax is generally 1% of the fair market value of the shares repurchased at the time of the repurchase. However, for purposes of calculating the excise tax, repurchasing corporations are permitted to net the fair market value of certain new stock issuances against the fair market value of stock repurchases during the same taxable year. In addition, certain exceptions apply to the excise tax. The U.S. Department of the Treasury (the “Treasury”) has been given authority to provide regulations and other guidance to carry out and prevent the abuse or avoidance of the excise tax. Any share redemption or other share repurchase that occurs after December 31, 2022, in connection with a Business Combination, extension vote or otherwise, may be subject to the excise tax. Whether and to what extent the Company would be subject to the excise tax in connection with a Business Combination, extension vote or otherwise will depend on a number of factors, including (i) the fair market value of the redemptions and repurchases in connection with the Business Combination, extension or otherwise, (ii) the structure of a Business Combination, (iii) the nature and amount of any “PIPE” or other equity issuances in connection with a Business Combination (or otherwise issued not in connection with a Business Combination but issued within the same taxable year of a Business Combination) and (iv) the content of regulations and other guidance from the Treasury. In addition, because the excise tax would be payable by the Company and not by the redeeming holder, the mechanics of any required payment of the excise tax have not been determined. The foregoing could cause a reduction in the cash available on hand to complete a Business Combination and in the Company’s ability to complete a Business Combination. On December 27, 2022, the Treasury Department and Internal Revenue Service (“IRS”) issued a Notice 2023-2 (“Notice”), which provided interim guidance regarding the application of the corporate stock repurchase excise tax until the issuance of proposed regulations. The Notice excluded the distributions from a complete liquidation of a corporation from the base of the excise tax. The Notice also excludes from the scope of the excise tax any distribution made during the taxable year in which a corporation fully liquidates and dissolves, even if a distribution precedes the formal decision to liquidate.

Restatement of Previously Issue

Restatement of Previously Issued Financial Statements	12 Months Ended
	Dec. 31, 2022
Restatement of Previously Issued Financial Statements [Abstract]
Restatement of Previously Issued Financial Statements	Note 2. Restatement of Previously Issued Financial Statements Subsequent to the initial issuance of the Company’s 2022 financial statements on April 7, 2023, management concluded that the previously issued audited financial statements for the year ended December 31, 2022 should be restated to correct the Consolidated Statements of Changes in Stockholders’ Deficit as the wrong net income was included in the statement. This clerical error had no impact on the Company’s cash position, revenues, or liquidity. The errors have been corrected by restating each of the affected financial statement line items for the period. Statement of Changes in Stockholders’ Deficit: The tables below present the effect of the financial statement adjustment related to the restatement discussed above of the Company’s previously reported accumulated deficit and total stockholder’s deficit within the statement of changes in stockholders’ deficit for the year ended December 31, 2022: For the year ended December 31, 2022 As Restatement As Restated Accumulated Deficit: Balance – December 31, 2021 $ (14,309,985 ) $ - $ (14,309,985 ) Net Income 3,937,702 2,624,373 6,562,075 Adjustment for accretion of Class A common stock subject to possible redemption amounts – accumulated deficit 5,749,511 - 5,749,511 Balance – December 31, 2022 $ (4,622,772 ) $ 2,624,373 $ (1,998,399 ) For the year ended December 31, 2022 As Restatement As Restated Total Stockholders’ Deficit: Balance – December 31, 2021 $ (14,309,554 ) $ - $ (14,309,554 ) Net Income 3,937,702 2,624,373 6,562,075 Adjustment for accretion of Class A common stock subject to possible redemption amounts – accumulated deficit 5,749,511 - 5,749,511 Balance – December 31, 2022 $ (4,622,341 ) $ 2,624,373 $ (1,997,968 ) Note 2A. Restatement of Previously Issued Financial Statements as of April 7, 2023 The Company had recognized a liability upon closing of their initial public offering in December 2020 for a portion of the underwriter’s commissions which was contingently payable upon closing of a future business combination, with the offsetting entry resulting in an initial discount to the securities sold in the initial public offering. On June 14, 2022, Cantor Fitzgerald & Co. irrevocably waived its rights to the deferred underwriting commissions due under the underwriting agreement. The Company recognized the waiver as an extinguishment, with a resulting non-operating gain recognized in its statements of operations reported in the Company’s Form 10-Qs for the quarterly periods ended June 30, 2022 and September 30, 2022 (the “Affected Quarterly Periods”). Upon subsequent review and analysis, management concluded that the Company should have recognized the portion allocated to Public Shares as an adjustment to the carrying value of the Class A common stock subject to possible redemption and the remaining balance as a gain from extinguishment of deferred underwriting commissions allocated to derivative warrant liabilities. Therefore, the Company’s management and the Audit Committee of the Company’s Board of Directors (the “Audit Committee”) concluded that the Company’s Affected Quarterly Periods should no longer be relied upon and that it is appropriate to restate them. As such, the Company will restate its financial statements in this Form 10-K/A. The previously presented Affected Quarterly Period should no longer be relied upon. Impact of the Restatement The impact of the restatement on the statements of operations, statements of changes in stockholders’ deficit and statements of cash flows for the affected period is presented below. The restatement had no impact on net cash flows from operating, investing or financing activities. Statement of Operations: The table below presents the effect of the financial statement adjustments related to the restatement discussed above of the Company’s previously reported statements of operations for the three and six months ended June 30, 2022: For the Three Months Ended June 30, 2022 (unaudited) As Previously Restatement As Restated Total operating expenses $ (1,120,935 ) $ - $ (1,120,935 ) Other income (expenses): Change in fair value of derivative warrant liabilities 2,290,750 - 2,290,750 Gain from extinguishment of deferred underwriting commissions allocated to derivative warrant liabilities 6,037,500 (5,749,511 ) 287,989 Interest earned on operating account 1 - 1 Income from investments held in Trust Account 166,440 - 166,440 Income before income tax expense 7,373,756 (5,749,511 ) 1,624,245 Income tax expense 6,535 - 6,535 Net income $ 7,367,221 $ (5,749,511 ) $ 1,617,710 Weighted average shares outstanding of Class A common stock, basic and diluted 15,484,292 - 15,484,292 Basic and diluted net income per share, Class A common stock $ 0.37 $ (0.29 ) $ 0.08 Weighted average shares outstanding of Class B common stock, basic and diluted 4,312,500 - 4,312,500 Basic and diluted net income per share, Class B common stock $ 0.37 $ (0.29 ) $ 0.08 For the Six Months Ended June 30, 2022 (unaudited) As Previously Restatement As Restated Total operating expenses $ (1,554,619 ) $ - $ (1,554,619 ) Other income (expenses): Change in fair value of derivative warrant liabilities 5,929,000 - 5,929,000 Gain from extinguishment of deferred underwriting commissions allocated to derivative warrant liabilities 6,037,500 (5,749,511 ) 287,989 Interest earned on operating account 3 - 3 Income from investments held in Trust Account 224,219 - 224,219 Income before income tax expense 10,636,103 (5,749,511 ) 4,886,592 Income tax expense 6,535 - 6,535 Net income $ 10,629,568 $ (5,749,511 ) $ 4,880,057 Weighted average shares outstanding of Class A common stock, basic and diluted 16,362,268 - 16,362,268 Basic and diluted net income per share, Class A common stock $ 0.51 $ (0.27 ) $ 0.24 Weighted average shares outstanding of Class B common stock, basic and diluted 4,312,500 - 4,312,500 Basic and diluted net income per share, Class B common stock $ 0.51 $ (0.27 ) $ 0.24 The table below presents the effect of the financial statement adjustments related to the restatement discussed above of the Company’s previously reported statement of operations for the nine months ended September 30, 2022 (there were no adjustments for the three months ended September 30, 2022): For the Nine Months Ended September 30, 2022 (unaudited) As Previously Restatement As Restated Total operating expenses $ (3,053,747 ) $ - $ (3,053,747 ) Other income (expenses): Change in fair value of derivative warrant liabilities 5,929,000 - 5,929,000 Gain from extinguishment of deferred underwriting commissions allocated to derivative warrant liabilities 6,037,500 (5,749,511 ) 287,989 Interest earned on operating account 4 - 4 Income from investments held in Trust Account 281,713 - 281,713 Income before income tax expense 9,194,470 (5,749,511 ) 3,444,959 Income tax expense 8,022 - 8,022 Net income $ 9,186,448 $ (5,749,511 ) $ 3,436,937 Weighted average shares outstanding of Class A common stock, basic and diluted 11,246,592 - 11,246,592 Basic and diluted net income per share, Class A common stock $ 0.59 $ (0.37 ) $ 0.22 Weighted average shares outstanding of Class B common stock, basic and diluted 4,312,500 - 4,312,500 Basic and diluted net income per share, Class B common stock $ 0.59 $ (0.37 ) $ 0.22 Statement of Changes in Stockholders’ Deficit: The table below presents the effect of the financial statement adjustments related to the restatement discussed above of the Company’s previously reported accumulated deficit within the statement of changes in stockholders’ deficit for the six months ended June 30, 2022: For the Six Months Ended June 30, 2022 (unaudited) As Previously Restatement As Restated Balance - December 31, 2021 $ (14,309,985 ) - $ (14,309,985 ) Net income 10,629,568 (5,749,511 ) 4,880,057 Adjustment for accretion of Class A common stock subject to possible redemption amount - accumulated deficit - 5,749,511 5,749,511 Balance - June 30, 2022 (unaudited) $ (3,680,417 ) $ - $ (3,680,417 ) The table below presents the effect of the financial statement adjustments related to the restatement discussed above of the Company’s previously reported accumulated deficit within the statement of changes in stockholders’ deficit for the nine months ended September 30, 2022: For the Nine Months Ended September 30, 2022 As Previously Reported Restatement Adjustment As Restated Balance - December 31, 2021 $ (14,309,985 ) - $ (14,309,985 ) Net income 9,186,448 (5,749,511 ) 3,436,937 Adjustment for accretion of Class A common stock subject to possible redemption amount - accumulated deficit - 5,749,511 5,749,511 Balance - September 30, 2022 (unaudited) $ (5,123,537 ) $ - $ (5,123,537 ) Statement of Cash Flows: The table below presents the effect of the financial statement adjustments related to the restatement discussed above of the Company’s previously reported statement of cash flows for the six months ended June 30, 2022: For the Six Months Ended June 30, 2022 (unaudited) As Previously Restatement As Restated Net income $ 10,629,568 $ (5,749,511 ) $ 4,880,057 Adjustments to reconcile net income to net cash used in operating activities: Change in fair value of derivative warrant liabilities (5,929,000 ) - (5,929,000 ) Gain from extinguishment of deferred underwriting commissions allocated to derivative warrant liabilities (6,037,500 ) 5,749,511 (287,989 ) Income from investments held in Trust Account (224,219 ) - (224,219 ) Changes in operating assets and liabilities: Prepaid expenses 57,723 - 57,723 Accounts payable 258,731 - 258,731 Accrued expenses 1,041,731 - 1,041,731 Due to related party (29,311 ) - (29,311 ) Franchise tax payable (70,522 ) - (70,522 ) Income tax payable 6,535 - 6,535 Net cash used in operating activities $ (296,264 ) $ - $ (296,264 ) Supplemental disclosure of noncash financing activities: Extinguishment of deferred underwriting commissions allocated to Public Shares $ - $ 5,749,511 $ 5,749,511 The table below presents the effect of the financial statement adjustments related to the restatement discussed above of the Company’s previously reported statement of cash flows for the nine months ended September 30, 2022: For the Nine Months Ended September 30, 2022 (unaudited) As Previously Restatement As Restated Net income $ 9,186,448 $ (5,749,511 ) $ 3,436,937 Adjustments to reconcile net income to net cash used in operating activities: Change in fair value of derivative warrant liabilities (5,929,000 ) - (5,929,000 ) Gain from extinguishment of deferred underwriting commissions allocated to derivative warrant liabilities (6,037,500 ) 5,749,511 (287,989 ) Income from investments held in Trust Account (281,713 ) - (281,713 ) Changes in operating assets and liabilities: Prepaid expenses 75,099 - 75,099 Accounts payable 1,498,738 - 1,498,738 Accrued expenses 1,227,066 - 1,227,066 Due to related party (29,311 ) - (29,311 ) Franchise tax payable (20,111 ) - (20,111 ) Income tax payable 8,022 - 8,022 Net cash used in operating activities $ (302,262 ) $ - $ (302,262 ) Supplemental disclosure of noncash financing activities: Extinguishment of deferred underwriting commissions allocated to Public Shares $ - $ 5,749,511 $ 5,749,511

Basis of Presentation and Summa

Basis of Presentation and Summary of Significant Accounting Policies	12 Months Ended
	Dec. 31, 2022
Basis of Presentation and Summary of Significant Accounting Policies [Abstract]
Basis of Presentation and Summary of Significant Accounting Policies	Note 3. Basis of Presentation and Summary of Significant Accounting Policies Basis of Presentation The accompanying consolidated financial statements are presented in U.S. dollars, in conformity with accounting principles generally accepted in the United States of America (“GAAP”) for financial information and pursuant to the rules and regulations of the SEC. The consolidated financial statements of the Company include its wholly owned subsidiary in connection with the planned merger. All inter-company accounts and transactions are eliminated in consolidation. Emerging Growth Company The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act of 2002, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved. Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that an emerging growth company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such an election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period, which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s consolidated financial statements with those of another public company that is neither an emerging growth company nor an emerging growth company that has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used. Use of Estimates The preparation of consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the consolidated financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. One of the more significant accounting estimates included in these consolidated financial statements is the determination of the fair value of the derivative warrant liabilities. Such estimates may be subject to change as more current information becomes available and accordingly, the actual results could differ significantly from those estimates. Cash and Cash Equivalents The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company had no cash equivalents as of December 31, 2022 and 2021. Concentration of Credit Risk Financial instruments that potentially subject the Company to concentration of credit risk consist of cash accounts in a financial institution which, at times, may exceed the Federal Deposit Insurance Corporation coverage limit of $250,000, and investments held in the trust account. Any loss incurred or a lack of access to such funds could have a significant adverse impact on the Company’s financial condition, results of operations, and cash flows. Investments Held in the Trust Account The Company’s portfolio of investments is comprised of U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act, with a maturity of 185 days or less, or investments in money market funds that invest in U.S. government securities and generally have a readily determinable fair value, or a combination thereof. When the Company’s investments held in the trust account are comprised of U.S. government securities, the investments are classified as trading securities. When the Company’s investments held in the trust account are comprised of money market funds, the investments are recognized at fair value. Trading securities and investments in money market funds are presented on the consolidated balance sheets at fair value at the end of each reporting period. Gains and losses resulting from the change in fair value of these securities is included in income on investments held in the trust account in the accompanying consolidated statements of operations. The estimated fair values of investments held in the trust account are determined using available market information. Fair Value Measurement Fair value is defined as the price that would be received for sale of an asset or paid for transfer of a liability, in an orderly transaction between market participants at the measurement date. GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers consist of: ● Level 1, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets; ● Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and ● Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable. In some circumstances, the inputs used to measure fair value might be categorized within different levels of the fair value hierarchy. In those instances, the fair value measurement is categorized in its entirety in the fair value hierarchy based on the lowest level input that is significant to the fair value measurement. Fair Value of Financial Instruments The fair value of the Company’s assets and liabilities which qualify as financial instruments under the FASB ASC Topic 820, “Fair Value Measurements,” equal or approximate the carrying amounts represented in the consolidated balance sheets, except for derivative warrant liabilities (see Note 10). Offering Costs Associated with the Initial Public Offering Offering costs consisted of legal, accounting, underwriting fees and other costs incurred that were directly related to the initial public offering. Offering costs are allocated to the separable financial instruments issued in the initial public offering based on a relative fair value basis, compared to total proceeds received. Offering costs associated with derivative warrant liabilities were expensed as incurred, presented as non-operating expenses in the consolidated statements of operations. Offering costs associated with the public shares were charged against the carrying value of the shares of Class A common stock upon the completion of the initial public offering. The Company classifies deferred underwriting commissions as non-current liabilities as their liquidation is not reasonably expected to require the use of current assets or require the creation of current liabilities. Derivative Warrant Liabilities The Company does not use derivative instruments to hedge exposures to cash flow, market, or foreign currency risks. The Company evaluates all of its financial instruments, including issued stock purchase warrants, to determine if such instruments are derivatives or contain features that qualify as embedded derivatives, pursuant to ASC 480 and ASC 815-15. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is re-assessed at the end of each reporting period. The warrants to purchase Class A common stock issued in connection with the initial public offering (the “public warrants”) and the private placement warrants are recognized as derivative liabilities in accordance with ASC 815. Accordingly, the Company recognizes the warrant instruments as liabilities at fair value and adjust the instruments to fair value at each reporting period. The liabilities are subject to re-measurement at each balance sheet date until exercised, and any change in fair value is recognized in the Company’s consolidated statements of operations. The initial fair value of the public warrants has been measured at fair value using a Monte Carlo simulation model. Subsequent to the public warrants being traded on an active market, the fair value of the public warrants has been based on the observable listed prices for such warrants. The fair value of the private placement warrants was estimated using Black-Scholes. The determination of the fair value of the warrant liability may be subject to change as more current information becomes available and accordingly the actual results could differ significantly. Derivative warrant liabilities are classified as non-current liabilities as their liquidation is not reasonably expected to require the use of current assets or require the creation of current liabilities. Class A Common Stock Subject to Possible Redemption The Company accounts for its Class A common stock subject to possible redemption in accordance with the guidance in ASC Topic 480 “Distinguishing Liabilities from Equity.” Shares of Class A common stock subject to mandatory redemption (if any) are classified as liability instruments and are measured at fair value. Shares of conditionally redeemable Class A common stock (including Class A common stock that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) are classified as temporary equity. At all other times, shares of Class A common stock are classified as stockholders’ equity. The Company’s Class A common stock feature certain redemption rights that are considered to be outside of the Company’s control and subject to the occurrence of uncertain future events. Accordingly, as of December 31, 2022 and 2021, a total of 1,182,054 and 17,250,000 shares of Class A common stock subject to possible redemption are presented at redemption value as temporary equity, outside of the stockholders’ deficit section of the Company’s consolidated balance sheets. Under ASC 480-10-S99, the Company has elected to recognize changes in the redemption value immediately as they occur and adjust the carrying value of the security to equal the redemption value at the end of the reporting period. This method would view the end of the reporting period as if it were also the redemption date of the security. Effective with the closing of the initial public offering, the Company recognized the accretion from initial book value to redemption amount, which resulted in charges against additional paid-in capital (to the extent available) and accumulated deficit. Net Income (Loss) Per Share of Common Stock The Company complies with accounting and disclosure requirements of FASB ASC Topic 260, “Earnings Per Share.” The Company has two classes of shares, which are referred to as Class A common stock and Class B common stock. Income and losses are shared pro rata between the two classes of shares. This presentation assumes a business combination as the most likely outcome. Net income (loss) per share of common stock is calculated by dividing the net income (loss) by the weighted average shares of common stock outstanding for the respective period. The calculation of diluted net income (loss) does not consider the effect of the warrants underlying the Units sold in the initial public offering (including the consummation of the over-allotment) and the private placement warrants to purchase an aggregate of 13,475,000 shares of Class A common stock in the calculation of diluted income (loss) per share of common stock, because their exercise is contingent upon future events. As a result, diluted net income (loss) per share is the same as basic net income (loss) per share of common stock for the years ended December 31, 2022 and 2021. Accretion associated with the redeemable Class A common stock is excluded from earnings per share as the redemption value approximates fair value. The table below presents a reconciliation of the numerator and denominator used to compute basic and diluted net income per share for each class of common stock: For the Years Ended December 31, 2022 2021 Class A Class B Class A Class B Basic and diluted net income per common stock: Numerator: Allocation of net income $ 4,388,957 $ 2,173,118 $ 4,438,620 $ 1,109,655 Denominator: Basic and diluted weighted average common stock outstanding 8,709,777 4,312,500 17,250,000 4,312,500 Basic and diluted net income per common stock $ 0.50 $ 0.50 $ 0.26 $ 0.26 Income Taxes The Company follows the asset and liability method of accounting for income taxes under FASB ASC 740, which requires an asset and liability approach to financial accounting and reporting for income taxes. Deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the consolidated financial statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that included the enactment date. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized. FASB ASC 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and the measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. The Company is subject to income tax examinations by major taxing authorities since inception. Recent Accounting Pronouncements In June 2022, the FASB issued ASU 2022-03, ASC Subtopic 820, “Fair Value Measurement of Equity Securities Subject to Contractual Sale Restrictions.” The ASU amends ASC 820 to clarify that a contractual sales restriction is not considered in measuring an equity security at fair value and to introduce new disclosure requirements for equity securities subject to contractual sale restrictions that are measured at fair value. The ASU applies to both holders and issuers of equity and equity-linked securities measured at fair value. The amendments in this ASU are effective for the Company in fiscal years beginning after December 15, 2023, and interim periods within those fiscal years. Early adoption is permitted for both interim and annual financial statements that have not yet been issued or made available for issuance. The Company is still evaluating the impact of this pronouncement on the consolidated financial statements. The Company’s management does not believe that any other recently issued, but not yet effective, accounting pronouncements, if currently adopted, would have a material effect on the Company’s consolidated financial statements.

Initial Public Offering

Initial Public Offering	12 Months Ended
	Dec. 31, 2022
Initial Public Offering [Abstract]
Initial Public Offering	Note 4. Initial Public Offering Public Units In the initial public offering, which closed December 22, 2020, the Company sold 17,250,000 units, including the issuance of 2,250,000 units as a result of the underwriters’ exercise of their over-allotment option in full, at a price of $10.00 per unit. Each unit consists of one share of Class A common stock and one-half of one redeemable warrant (each whole warrant, a “warrant”). Each whole warrant entitles the holder to purchase one share of Class A common stock at a price of $11.50 per share. Each warrant will become exercisable on the later of 30 days after the completion of the Company’s initial business combination and 12 months from the closing of the initial public offering. The exercise price and number of shares of Class A common stock issuable upon exercise of the warrants may be adjusted in certain circumstances including in the event of a stock dividend, or recapitalization, reorganization, merger or consolidation. The Company granted the underwriters a 45-day option to purchase up to 2,250,000 additional units to cover any over-allotment, at the initial public offering price less the underwriting discounts and commissions. The Company issued 2,250,000 units in connection with the underwriters’ exercise of the over-allotment option in full.

Related Party Transactions

Related Party Transactions	12 Months Ended
	Dec. 31, 2022
Related Party Transactions [Abstract]
Related Party Transactions	Note 5. Related Party Transactions Founder Shares On July 10, 2020, the Sponsor purchased 3,737,500 shares of the Company’s Class B common stock, par value $0.0001 per share, (the “Founder Shares”) for an aggregate price of $25,000. On December 17, 2020, pursuant to the amended and restated certificate of incorporation, each founder share outstanding immediately prior to December 17, 2020 was converted into one and two-thirteenths (1 2 13 The initial stockholders agreed, subject to limited exceptions, not to transfer, assign or sell any of the Founder Shares until the earlier to occur of (A) one year after the completion of the initial business combination or earlier if, subsequent to the initial business combination, the closing price of the Class A common stock equals or exceeds $12.00 per share (as adjusted for stock splits, stock capitalizations, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day period commencing at least 150 days after the initial business combination, and (B) the date following the completion of the initial business combination on which the Company completes a liquidation, merger, capital stock exchange or other similar transaction that results in all of the stockholders having the right to exchange their Class A common stock for cash, securities or other property. Private Placement Warrants Simultaneously with the closing of the initial public offering, the Company consummated the private placement of 4,850,000 private placement warrants at a price of $1.00 per private placement warrant to the Sponsor, generating proceeds of $4,850,000. Each private placement warrant is exercisable for one whole share of Class A common stock at a price of $11.50 per share. A portion of the proceeds from the sale of the private placement warrants to the Sponsor was added to the proceeds from the initial public offering held in the trust account such that at closing of the initial public offering, $172,000,000 was placed in the trust account. The private placement warrants (including the shares of common stock issuable upon exercise of the private placement warrants) are not transferable, assignable or salable until 30 days after the completion of the initial business combination and they are non-redeemable and exercisable on a cashless basis so long as they are held by the initial purchasers of the private placement warrants or their permitted transferees. If the private placement warrants are held by someone other than the initial purchasers of the private placement warrants or their permitted transferees, the private placement warrants will be redeemable for cash by the Company and exercisable by such holders on the same basis as the warrants included in the Units sold in the initial public offering. Otherwise, the private placement warrants have terms and provisions that are identical to those of the Warrants sold as part of the Units in the initial public offering and have no net cash settlement provisions. If the Company does not complete a business combination, then the proceeds will be part of the liquidating distribution to the public stockholders and the warrants issued to the Sponsor will expire worthless. Related Party Loans On June 18, 2020, the Sponsor agreed to loan the Company an aggregate of up to $200,000 to cover expenses related to the initial public offering pursuant to a promissory note (the “Note”). This loan was non-interest bearing and payable upon the completion of the initial public offering. The Company borrowed approximately $31,000 under the Note and fully repaid the Note in full on December 22, 2020. Subsequent to the repayment, the facility was no longer available to the Company. In addition, in order to finance transaction costs in connection with a business combination, the Sponsor or an affiliate of the Sponsor, or certain of the Company’s officers and directors may, but are not obligated to, loan the Company funds as may be required (the “working capital loans”). If the Company completes a business combination, the Company will repay the working capital loans out of the proceeds of the trust account released to the Company. Otherwise, the working capital loans would be repaid only out of funds held outside the trust account. In the event that a business combination does not close, the Company may use a portion of proceeds held outside the trust account to repay the working capital loans, but no proceeds held in the trust account would be used to repay the working capital loans. The working capital loans would either be repaid upon consummation of a business combination or, at the lenders’ discretion, up to $1,500,000 of such working capital loans may be convertible into warrants of the post business combination entity at a price of $1.00 per warrant. The warrants would be identical to the private placement warrants. Except for the foregoing, the terms of such working capital loans, if any, have not been determined and no written agreements exist with respect to such loans. As of December 31, 2022 and 2021, the Company had no borrowings under working capital loans. Administrative Services Agreement Commencing on the date that the Company’s securities were first listed on Nasdaq until the earlier of the Company’s consummation of a Business Combination or the Company’s liquidation, the Company agreed to pay the Sponsor a total of $10,000 per month for office space, secretarial and administrative services provided to members of the Company’s management team. For the years ended December 31, 2022 and 2021, the Company had incurred $120,000 and $120,000 in administrative services expenses under this agreement, respectively. As of December 31, 2022 and 2021, the Company had $0 and $20,000 outstanding, respectively, for services in connection with such agreement on the accompanying consolidated balance sheets. The Sponsor, officers and directors, or any of their respective affiliates will be reimbursed for any out-of-pocket expenses incurred in connection with activities on the Company’s behalf such as identifying potential target businesses and performing due diligence on suitable business combinations. The Company’s audit committee will review on a quarterly basis all payments that were made by the Company to the Sponsor, directors, officers or directors of the Company, or any of their affiliates. As of December 31, 2022 and 2021, there were $1,500 and $30,811 due to related party respectively.

Commitments and Contingencies

Commitments and Contingencies	12 Months Ended
	Dec. 31, 2022
Commitments and Contingencies [Abstract]
Commitments and Contingencies	Note 6. Commitments and Contingencies Registration Rights The holders of Founder Shares, private placement warrants and warrants that may be issued upon conversion of working capital loans, if any, (and any underlying securities) are entitled to registration rights pursuant to a registration rights agreement. These holders are entitled to make up to three demands, excluding short form demands, that we register such securities. In addition, the holders have certain “piggy-back” registration rights with respect to registration statements filed subsequent to the completion of the initial business combination. The Company will bear the expenses incurred in connection with the filing of any such registration statements. Underwriting Agreement The Company granted the underwriters a 45-day option to purchase up to 2,250,000 additional units to cover any over-allotment, at the initial public offering price less the underwriting discounts and commissions. On December 22, 2020 Company issued 2,250,000 units in connection with the underwriters’ exercise of the over-allotment option in full. The Company paid an underwriting discount of $3,450,000 ($0.20 per unit sold) to the underwriters at the closing of the initial public offering on December 22, 2020, with an additional fee (the “Deferred Discount”) of $6,037,500 ($0.35 per unit sold) payable upon the Company’s completion of an initial business combination. On June 14, 2022, the Company entered into a letter agreement (the “Amendment Letter”) with Cantor Fitzgerald & Co. (“Cantor”) to amend that certain underwriting agreement (the “Underwriting Agreement”), dated December 17, 2020, by and between the Company and Cantor, as representative of the several underwriters named therein (the “Underwriters”), pursuant to which Cantor agreed to waive in full the Deferred Discount. Pursuant to the Amendment Letter, the Company agreed to grant Cantor with a right of first refusal to act as the Company’s capital markets advisor with an advisory fee of $3,800,000, subject to the conditions described in the Amendment Letter.

Derivative Warrant Liabilities

Derivative Warrant Liabilities	12 Months Ended
	Dec. 31, 2022
Derivative Warrant Liabilities [Abstract]
Derivative Warrant Liabilities	Note 7. Derivative Warrant Liabilities As of December 31, 2022 and 2021, the Company had 8,625,000 and 4,850,000 public warrants and private placement warrants outstanding. Public warrants may only be exercised for a whole number of shares. No fractional public warrants will be issued upon separation of the Units and only whole public warrants will trade. The public warrants will become exercisable on the later of (a) 30 days after the completion of a business combination or (b) 12 months from the closing of the initial public offering; provided in each case that the Company has an effective registration statement under the Securities Act covering the shares of Class A common stock issuable upon exercise of the public warrants and a current prospectus relating to them is available (or the Company permits holders to exercise their public warrants on a cashless basis and such cashless exercise Is exempt from registration under the Securities Act). The Company has agreed that as soon as practicable, but in no event later than 15 business days, after the closing of a business combination, the Company will use its best efforts to file with the SEC a registration statement for the registration, under the Securities Act, of the shares of Class A common stock issuable upon exercise of the public warrants. The Company will use its best efforts to cause the same to become effective and to maintain the effectiveness of such registration statement, and a current prospectus relating thereto, until the expiration of the public warrants in accordance with the provisions of the warrant agreement. Notwithstanding the above, if the Class A common stock is at the time of any exercise of a warrant not listed on a national securities exchange such that it satisfies the definition of a “covered security” under Section 18(b)(1) of the Securities Act, the Company may, at its option, require holders of public warrants who exercise their warrants to do so on a “cashless” basis, and, in the event the Company so elects, the Company will not be required to file or maintain in effect a registration statement, but the Company will be required to use its best efforts to register or qualify the shares under applicable blue sky laws to the extent an exemption is not available. The public warrants will expire five years after the completion of a business combination or earlier upon redemption or liquidation. If (x) the Company issues additional shares of Class A common stock or equity-linked securities for capital raising purposes in connection with the closing of its initial business combination at an issue price or effective issue price of less than $9.20 per share of Class A common stock (with such issue price or effective issue price to be determined in good faith by the Company’s board of directors and, in the case of any such issuance to the initial stockholders or their affiliates, without taking into account any Founder Shares held by the initial stockholders or such affiliates, as applicable, prior to such issuance), (y) the aggregate gross proceeds from such issuances represent more than 60% of the total equity proceeds, and interest thereon, available for the funding of the initial business combination (net of redemptions), and (z) the volume weighted average trading price of the Class A common stock during the 20 trading day period starting on the trading day after the day on which the Company consummates the initial business combination (such price, the “Market Value”) is below $9.20 per share, the exercise price of the Warrants will be adjusted (to the nearest cent) to be equal to 115% of the higher of the Market Value and the Newly Issued Price, and the $18.00 per share redemption trigger price of the Warrants will be adjusted (to the nearest cent) to be equal to 180% of the higher of the Market Value and the Newly Issued Price. The private placement warrants are identical to the public warrants, except that the private placement warrants and the shares of Class A common stock issuable upon exercise of the private placement warrants will not be transferable, assignable or salable until 30 days after the completion of a business combination, subject to certain limited exceptions. Additionally, the private placement warrants will be non-redeemable so long as they are held by the Sponsor or its permitted transferees. If the private placement warrants are held by someone other than the Sponsor or its permitted transferees, the private placement warrants will be redeemable by the Company and exercisable by such holders on the same basis as the public warrants. The Company may call the Public Warrants for redemption: ● in whole and not in part; ● at a price of $0.01 per warrant; ● upon a minimum of 30 days’ prior written notice of redemption; and ● if, and only if, the last sales price of the Class A common stock equals or exceeds $18.00 per share on each of 20 trading days within the 30-trading day period ending on the third business day prior to the date on which the Company sends the notice of redemption to the warrant holders. If the Company calls the Public Warrants for redemption, management will have the option to require all holders that wish to exercise the Public Warrants to do so on a “cashless basis,” as described in the warrant agreement. If the Company is unable to complete a business combination within the Combination Period and the Company liquidates the funds held in the trust account, holders of warrants will not receive any of such funds with respect to their warrants, nor will they receive any distribution from the Company’s assets held outside of the trust account with the respect to such warrants. Accordingly, the warrants may expire worthless.

Class A Common Stock Subject to

Class A Common Stock Subject to Possible Redemption	12 Months Ended
	Dec. 31, 2022
Class A Common Stock Subject to Possible Redemption [Abstract]
Class A Common Stock Subject to Possible Redemption	Note 8. Class A Common Stock Subject to Possible Redemption The Company’s Class A common stock feature certain redemption rights that are considered to be outside of the Company’s control and subject to the occurrence of future events. The Company is authorized to issue 380,000,000 shares of Class A common stock with a par value of $0.0001 per share. Holders of the Company’s Class A common stock are entitled to one vote for each share. As of December 31, 2022 and 2021, there were 1,182,054 and 17,250,000 shares of Class A common stock outstanding, respectively, which were all subject to possible redemption and classified outside of permanent equity in the consolidated balance sheets. The Class A common stock subject to possible redemption reflected on the consolidated balance sheets is reconciled on the following table: Gross proceeds $ 172,500,000 Less: Fair value of Public Warrants at issuance (8,226,780 ) Offering costs allocated to Class A common stock subject to possible redemption (9,544,063 ) Plus: Accretion on Class A common stock subject to possible redemption amount 17,770,843 Class A common stock subject to possible redemption, December 31, 2021 172,500,000 Less: Redemption of Class A common stock subject to possible redemption (160,679,460 ) Adjustment for accretion of Class A common stock subject to possible redemption amount (5,749,511 ) Plus: Waiver of offering costs allocated to Class A common stock subject to possible redemption 5,749,511 Class A common stock subject to possible redemption, December 31, 2022 $ 11,820,540

Stockholders_ Deficit

Stockholders’ Deficit	12 Months Ended
	Dec. 31, 2022
Stockholders’ Deficit [Abstract]
Stockholders’ Deficit	Note 9. Stockholders’ Deficit Preferred Stock Class A Common Stock Class B Common Stock (Founder Shares) Stockholders of record are entitled to one vote for each share held on all matters to be voted on by stockholders. Holders of Class A common stock and holders of Class B common stock will vote together as a single class on all matters submitted to a vote of our stockholders except as required by law. The Class B common stock will automatically convert into Class A common stock at the time of the initial business combination on a one-for-one basis, subject to adjustment for stock splits, stock dividends, reorganizations, recapitalizations and the like, and subject to further adjustment as provided herein. In the case that additional shares of Class A common stock or equity-linked securities are issued or deemed issued in connection with the initial business combination, the number of shares of Class A common stock issuable upon conversion of all founder shares will equal, in the aggregate, on an as-converted basis, 20% of the total number of shares of Class A common stock outstanding after such conversion (after giving effect to any redemptions of shares of Class A common stock by public stockholders), including the total number of shares of Class A common stock issued, or deemed issued or issuable upon conversion or exercise of any equity-linked securities or rights issued or deemed issued, by the company in connection with or in relation to the consummation of the initial business combination, excluding any shares of Class A common stock or equity-linked securities or rights exercisable for or convertible into shares of Class A common stock issued, or to be issued, to any seller in the initial business combination and any private placement warrants issued to the Sponsor, officers or directors upon conversion of working capital loans, provided that such conversion of founder shares will never occur on a less than one-for-one basis.

Fair Value Measurements

Fair Value Measurements	12 Months Ended
	Dec. 31, 2022
Fair Value Measurements [Abstract]
Fair Value Measurements	Note 10. Fair Value Measurements The public warrants were initially measured utilizing a Monte Carlo simulation model, and the private placement warrants were measured utilizing a Black-Scholes model. Subsequently when the public warrants were separately listed and traded in an active market, the public warrants have been measured at fair value utilizing their listed trading price. For the year ended December 31, 2022 and 2021, the Company recognized a gain/(loss) from a decrease/(increase) in the fair value of liabilities of approximately $6.5 million and $8.0 million, respectively, presented as a change in fair value of derivative warrant liabilities in the accompanying consolidated statements of operations. The estimated fair value of private placement warrants as of December 31, 2022 was based on the fair value of the public warrants and the estimated fair value of the private placement warrants as of December 31, 2021 were determined utilizing Level 3 inputs. Inherent in a Monte Carlo simulation and Black-Scholes model are assumptions related to expected stock-price volatility, expected life, risk-free interest rate and dividend yield. The Company estimates the volatility of its common stock warrants based on implied volatility from the Company’s traded warrants and from historical volatility of select peer company’s common stock that matches the expected remaining life of the warrants. The risk-free interest rate is based on the U.S. Treasury zero-coupon yield curve on the grant date for a maturity similar to the expected remaining life of the warrants. The expected life of the warrants is assumed to be equivalent to their remaining contractual term. The dividend rate is based on the historical rate, which the Company anticipates remaining at zero. The most significant input is volatility and significant increases (decreases) in the expected volatility in isolation would result in a significantly higher (lower) fair value measurement. The following table presents information about the Company’s financial assets and liabilities that are measured at fair value on a recurring basis as of December 31, 2022 and 2021 by level within the fair value hierarchy: December 31, 2022 Description Quoted Significant Significant Liabilities Derivative warrant liabilities – Public $ 86,250 $ - $ - Derivative warrant liabilities – Private Placement $ - $ 48,500 $ - December 31, 2021 Description Quoted Significant Significant Assets: Investments held in Trust Account – U.S. Treasury securities $ 172,543,076 $ - $ - Liabilities: Derivative warrant liabilities – Public $ 4,226,250 $ - $ - Derivative warrant liabilities – Private Placement $ - $ - $ 2,376,500 As of December 31, 2022, the trust assets were all held in cash. Transfers to/from Levels 1, 2 and 3 are recognized at the beginning of the reporting period. The estimated fair value of public warrants was transferred from a Level 3 fair value measurement to a Level 1 measurement when the public warrants were separately listed and traded in February 2021. There were no other transfers to/from Levels 1, 2, and 3 during the year ended December 31, 2021. The estimated fair value of the private placement warrants was transferred from a Level 3 fair value measurement to a Level 2 measurement on July 1, 2022. As the transfer of private placement warrants to anyone who is not a permitted transferee would result in the private placement warrants having substantially the same terms as the public warrants, the Company determined that the fair value of each private placement warrant is equivalent to that of each public warrant. There were no other transfers to/from Levels 1, 2, and 3 during the year ended December 31, 2022. The following table provides quantitative information regarding Level 3 fair value measurements inputs at their measurement dates: As of Exercise price $ 11.50 Unit price $ 10.15 Volatility 8.80 % Stock price $ 9.90 Expected life of the options to convert (years) 5.42 Risk-free rate 1.29 % The changes in the fair value of the derivative warrant liabilities, measured using Level 3 inputs, for the years ended December 31, 2022 and 2021, are summarized as follows: 2022 2021 Derivative warrant liabilities as of January 1 $ 2,376,500 $ 14,580,610 Transfer out of Level 3, Public Warrants start trading - (5,354,620 ) Transfer of Private Placement Warrants to Level 2 (242,500 ) - Change in fair value of derivative warrant liabilities – Level 3 (2,134,000 ) (6,849,490 ) Derivative warrant liabilities as of December 31 – Level 3 $ - $ 2,376,500

Income Taxes

Income Taxes	12 Months Ended
	Dec. 31, 2022
Income Taxes [Abstract]
Income Taxes	Note 11. Income Taxes The Company’s general and administrative expenses are generally considered start-up costs and are not currently deductible. There was no income tax expense for the year ended December 31, 2021. The income tax provision (benefit) consists of the following: For the Years Ended 2022 2021 Current Federal $ 73,131 $ - State - - Deferred Federal (137,164 ) (510,213 ) State - - Valuation allowance 137,164 510,213 Income tax provision $ 73,131 $ - The Company’s net deferred tax assets are as follows: December 31, 2022 2021 Deferred tax assets: Start-up/Organization costs $ 636,790 $ 499,627 Net operating loss carryforwards - 39,808 Total deferred tax assets 636,790 539,435 Valuation allowance (636,790 ) (539,435 ) Deferred tax asset, net of allowance $ - $ - In assessing the realization of deferred tax assets, management considers whether it is more likely than not that some portion or all of the deferred tax assets will not be realized. The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income during the periods in which temporary differences representing net future deductible amounts become deductible. Management considers the scheduled reversal of deferred tax assets, projected future taxable income and tax planning strategies in making this assessment. After consideration of all of the information available, management believes that significant uncertainty exists with respect to future realization of the deferred tax assets and has therefore established a full valuation allowance. For the years ended December 31, 2022 and 2021, the valuation allowance increased by approximately $0.6 million and approximately $0.5 million, respectively. As of December 31, 2022 and 2021, the Company had $0 and approximately $190,000, respectively, of U.S. federal net operating loss carryovers, which do not expire, available to offset future taxable income. There were no unrecognized tax benefits as of December 31, 2022 and 2021. No amounts were accrued for the payment of interest and penalties as of December 31, 2022 and 2021. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. The Company is subject to income tax examinations by major taxing authorities since inception. A reconciliation of the statutory federal income tax rate (benefit) to the Company’s effective tax rate (benefit) is as follows: For the Years Ended 2022 2021 Statutory federal income tax rate 21.0 % 21.0 % Change in fair value of warrant liabilities -20.5 % -30.2 % Gain from extinguishment of deferred underwriting commissions allocated to derivative warrant liabilities -0.9 % 0.0 % Change in valuation allowance 2.1 % 9.2 % Income tax expense 1.7 % 0.0 %

Subsequent Events

Subsequent Events	12 Months Ended
	Dec. 31, 2022
Subsequent Events [Abstract]
Subsequent Events	Note 12. Subsequent Events Management has evaluated subsequent events and transactions that occurred after the balance sheet date up to the date that the consolidated financial statements were issued and determined that other than the settlement of the lawsuit with TradeZero as described in Note 1, there have been no events that have occurred that would require adjustments to the disclosures in the consolidated financial statements.

Accounting Policies, by Policy

Accounting Policies, by Policy (Policies)	12 Months Ended
	Dec. 31, 2022
Description of Organization and Business Operations [Abstract]
Basis of Presentation	Basis of Presentation The accompanying consolidated financial statements are presented in U.S. dollars, in conformity with accounting principles generally accepted in the United States of America (“GAAP”) for financial information and pursuant to the rules and regulations of the SEC. The consolidated financial statements of the Company include its wholly owned subsidiary in connection with the planned merger. All inter-company accounts and transactions are eliminated in consolidation.
Emerging Growth Company	Emerging Growth Company The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act of 2002, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved. Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that an emerging growth company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such an election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period, which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s consolidated financial statements with those of another public company that is neither an emerging growth company nor an emerging growth company that has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.
Use of Estimates	Use of Estimates The preparation of consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the consolidated financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. One of the more significant accounting estimates included in these consolidated financial statements is the determination of the fair value of the derivative warrant liabilities. Such estimates may be subject to change as more current information becomes available and accordingly, the actual results could differ significantly from those estimates.
Cash and Cash Equivalents	Cash and Cash Equivalents The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company had no cash equivalents as of December 31, 2022 and 2021.
Concentration of Credit Risk	Concentration of Credit Risk Financial instruments that potentially subject the Company to concentration of credit risk consist of cash accounts in a financial institution which, at times, may exceed the Federal Deposit Insurance Corporation coverage limit of $250,000, and investments held in the trust account. Any loss incurred or a lack of access to such funds could have a significant adverse impact on the Company’s financial condition, results of operations, and cash flows.
Investments Held in the Trust Account	Investments Held in the Trust Account The Company’s portfolio of investments is comprised of U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act, with a maturity of 185 days or less, or investments in money market funds that invest in U.S. government securities and generally have a readily determinable fair value, or a combination thereof. When the Company’s investments held in the trust account are comprised of U.S. government securities, the investments are classified as trading securities. When the Company’s investments held in the trust account are comprised of money market funds, the investments are recognized at fair value. Trading securities and investments in money market funds are presented on the consolidated balance sheets at fair value at the end of each reporting period. Gains and losses resulting from the change in fair value of these securities is included in income on investments held in the trust account in the accompanying consolidated statements of operations. The estimated fair values of investments held in the trust account are determined using available market information.
Fair Value Measurement	Fair Value Measurement Fair value is defined as the price that would be received for sale of an asset or paid for transfer of a liability, in an orderly transaction between market participants at the measurement date. GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers consist of: ● Level 1, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets; ● Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and ● Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable. In some circumstances, the inputs used to measure fair value might be categorized within different levels of the fair value hierarchy. In those instances, the fair value measurement is categorized in its entirety in the fair value hierarchy based on the lowest level input that is significant to the fair value measurement.
Fair Value of Financial Instruments	Fair Value of Financial Instruments The fair value of the Company’s assets and liabilities which qualify as financial instruments under the FASB ASC Topic 820, “Fair Value Measurements,” equal or approximate the carrying amounts represented in the consolidated balance sheets, except for derivative warrant liabilities (see Note 10).
Offering Costs Associated with the Initial Public Offering	Offering Costs Associated with the Initial Public Offering Offering costs consisted of legal, accounting, underwriting fees and other costs incurred that were directly related to the initial public offering. Offering costs are allocated to the separable financial instruments issued in the initial public offering based on a relative fair value basis, compared to total proceeds received. Offering costs associated with derivative warrant liabilities were expensed as incurred, presented as non-operating expenses in the consolidated statements of operations. Offering costs associated with the public shares were charged against the carrying value of the shares of Class A common stock upon the completion of the initial public offering. The Company classifies deferred underwriting commissions as non-current liabilities as their liquidation is not reasonably expected to require the use of current assets or require the creation of current liabilities.
Derivative Warrant Liabilities	Derivative Warrant Liabilities The Company does not use derivative instruments to hedge exposures to cash flow, market, or foreign currency risks. The Company evaluates all of its financial instruments, including issued stock purchase warrants, to determine if such instruments are derivatives or contain features that qualify as embedded derivatives, pursuant to ASC 480 and ASC 815-15. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is re-assessed at the end of each reporting period. The warrants to purchase Class A common stock issued in connection with the initial public offering (the “public warrants”) and the private placement warrants are recognized as derivative liabilities in accordance with ASC 815. Accordingly, the Company recognizes the warrant instruments as liabilities at fair value and adjust the instruments to fair value at each reporting period. The liabilities are subject to re-measurement at each balance sheet date until exercised, and any change in fair value is recognized in the Company’s consolidated statements of operations. The initial fair value of the public warrants has been measured at fair value using a Monte Carlo simulation model. Subsequent to the public warrants being traded on an active market, the fair value of the public warrants has been based on the observable listed prices for such warrants. The fair value of the private placement warrants was estimated using Black-Scholes. The determination of the fair value of the warrant liability may be subject to change as more current information becomes available and accordingly the actual results could differ significantly. Derivative warrant liabilities are classified as non-current liabilities as their liquidation is not reasonably expected to require the use of current assets or require the creation of current liabilities.
Class A Common Stock Subject to Possible Redemption	Class A Common Stock Subject to Possible Redemption The Company accounts for its Class A common stock subject to possible redemption in accordance with the guidance in ASC Topic 480 “Distinguishing Liabilities from Equity.” Shares of Class A common stock subject to mandatory redemption (if any) are classified as liability instruments and are measured at fair value. Shares of conditionally redeemable Class A common stock (including Class A common stock that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) are classified as temporary equity. At all other times, shares of Class A common stock are classified as stockholders’ equity. The Company’s Class A common stock feature certain redemption rights that are considered to be outside of the Company’s control and subject to the occurrence of uncertain future events. Accordingly, as of December 31, 2022 and 2021, a total of 1,182,054 and 17,250,000 shares of Class A common stock subject to possible redemption are presented at redemption value as temporary equity, outside of the stockholders’ deficit section of the Company’s consolidated balance sheets. Under ASC 480-10-S99, the Company has elected to recognize changes in the redemption value immediately as they occur and adjust the carrying value of the security to equal the redemption value at the end of the reporting period. This method would view the end of the reporting period as if it were also the redemption date of the security. Effective with the closing of the initial public offering, the Company recognized the accretion from initial book value to redemption amount, which resulted in charges against additional paid-in capital (to the extent available) and accumulated deficit.
Net Income (Loss) Per Share of Common Stock	Net Income (Loss) Per Share of Common Stock The Company complies with accounting and disclosure requirements of FASB ASC Topic 260, “Earnings Per Share.” The Company has two classes of shares, which are referred to as Class A common stock and Class B common stock. Income and losses are shared pro rata between the two classes of shares. This presentation assumes a business combination as the most likely outcome. Net income (loss) per share of common stock is calculated by dividing the net income (loss) by the weighted average shares of common stock outstanding for the respective period. The calculation of diluted net income (loss) does not consider the effect of the warrants underlying the Units sold in the initial public offering (including the consummation of the over-allotment) and the private placement warrants to purchase an aggregate of 13,475,000 shares of Class A common stock in the calculation of diluted income (loss) per share of common stock, because their exercise is contingent upon future events. As a result, diluted net income (loss) per share is the same as basic net income (loss) per share of common stock for the years ended December 31, 2022 and 2021. Accretion associated with the redeemable Class A common stock is excluded from earnings per share as the redemption value approximates fair value. The table below presents a reconciliation of the numerator and denominator used to compute basic and diluted net income per share for each class of common stock: For the Years Ended December 31, 2022 2021 Class A Class B Class A Class B Basic and diluted net income per common stock: Numerator: Allocation of net income $ 4,388,957 $ 2,173,118 $ 4,438,620 $ 1,109,655 Denominator: Basic and diluted weighted average common stock outstanding 8,709,777 4,312,500 17,250,000 4,312,500 Basic and diluted net income per common stock $ 0.50 $ 0.50 $ 0.26 $ 0.26
Income Taxes	Income Taxes The Company follows the asset and liability method of accounting for income taxes under FASB ASC 740, which requires an asset and liability approach to financial accounting and reporting for income taxes. Deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the consolidated financial statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that included the enactment date. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized. FASB ASC 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and the measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. The Company is subject to income tax examinations by major taxing authorities since inception.
Recent Accounting Pronouncements	Recent Accounting Pronouncements In June 2022, the FASB issued ASU 2022-03, ASC Subtopic 820, “Fair Value Measurement of Equity Securities Subject to Contractual Sale Restrictions.” The ASU amends ASC 820 to clarify that a contractual sales restriction is not considered in measuring an equity security at fair value and to introduce new disclosure requirements for equity securities subject to contractual sale restrictions that are measured at fair value. The ASU applies to both holders and issuers of equity and equity-linked securities measured at fair value. The amendments in this ASU are effective for the Company in fiscal years beginning after December 15, 2023, and interim periods within those fiscal years. Early adoption is permitted for both interim and annual financial statements that have not yet been issued or made available for issuance. The Company is still evaluating the impact of this pronouncement on the consolidated financial statements. The Company’s management does not believe that any other recently issued, but not yet effective, accounting pronouncements, if currently adopted, would have a material effect on the Company’s consolidated financial statements.

Restatement of Previously Iss_2

Restatement of Previously Issued Financial Statements (Tables)	12 Months Ended
	Dec. 31, 2022
Restatement of Previously Issued Financial Statements [Abstract]
Schedule of company’s previously reported statement of changes in stockholders’ deficit	For the year ended December 31, 2022 As Restatement As Restated Accumulated Deficit: Balance – December 31, 2021 $ (14,309,985 ) $ - $ (14,309,985 ) Net Income 3,937,702 2,624,373 6,562,075 Adjustment for accretion of Class A common stock subject to possible redemption amounts – accumulated deficit 5,749,511 - 5,749,511 Balance – December 31, 2022 $ (4,622,772 ) $ 2,624,373 $ (1,998,399 ) For the year ended December 31, 2022 As Restatement As Restated Total Stockholders’ Deficit: Balance – December 31, 2021 $ (14,309,554 ) $ - $ (14,309,554 ) Net Income 3,937,702 2,624,373 6,562,075 Adjustment for accretion of Class A common stock subject to possible redemption amounts – accumulated deficit 5,749,511 - 5,749,511 Balance – December 31, 2022 $ (4,622,341 ) $ 2,624,373 $ (1,997,968 ) For the Six Months Ended June 30, 2022 (unaudited) As Previously Restatement As Restated Balance - December 31, 2021 $ (14,309,985 ) - $ (14,309,985 ) Net income 10,629,568 (5,749,511 ) 4,880,057 Adjustment for accretion of Class A common stock subject to possible redemption amount - accumulated deficit - 5,749,511 5,749,511 Balance - June 30, 2022 (unaudited) $ (3,680,417 ) $ - $ (3,680,417 ) For the Nine Months Ended September 30, 2022 As Previously Reported Restatement Adjustment As Restated Balance - December 31, 2021 $ (14,309,985 ) - $ (14,309,985 ) Net income 9,186,448 (5,749,511 ) 3,436,937 Adjustment for accretion of Class A common stock subject to possible redemption amount - accumulated deficit - 5,749,511 5,749,511 Balance - September 30, 2022 (unaudited) $ (5,123,537 ) $ - $ (5,123,537 )
Schedule of company’s previously reported statements of operations	For the Three Months Ended June 30, 2022 (unaudited) As Previously Restatement As Restated Total operating expenses $ (1,120,935 ) $ - $ (1,120,935 ) Other income (expenses): Change in fair value of derivative warrant liabilities 2,290,750 - 2,290,750 Gain from extinguishment of deferred underwriting commissions allocated to derivative warrant liabilities 6,037,500 (5,749,511 ) 287,989 Interest earned on operating account 1 - 1 Income from investments held in Trust Account 166,440 - 166,440 Income before income tax expense 7,373,756 (5,749,511 ) 1,624,245 Income tax expense 6,535 - 6,535 Net income $ 7,367,221 $ (5,749,511 ) $ 1,617,710 Weighted average shares outstanding of Class A common stock, basic and diluted 15,484,292 - 15,484,292 Basic and diluted net income per share, Class A common stock $ 0.37 $ (0.29 ) $ 0.08 Weighted average shares outstanding of Class B common stock, basic and diluted 4,312,500 - 4,312,500 Basic and diluted net income per share, Class B common stock $ 0.37 $ (0.29 ) $ 0.08 For the Six Months Ended June 30, 2022 (unaudited) As Previously Restatement As Restated Total operating expenses $ (1,554,619 ) $ - $ (1,554,619 ) Other income (expenses): Change in fair value of derivative warrant liabilities 5,929,000 - 5,929,000 Gain from extinguishment of deferred underwriting commissions allocated to derivative warrant liabilities 6,037,500 (5,749,511 ) 287,989 Interest earned on operating account 3 - 3 Income from investments held in Trust Account 224,219 - 224,219 Income before income tax expense 10,636,103 (5,749,511 ) 4,886,592 Income tax expense 6,535 - 6,535 Net income $ 10,629,568 $ (5,749,511 ) $ 4,880,057 Weighted average shares outstanding of Class A common stock, basic and diluted 16,362,268 - 16,362,268 Basic and diluted net income per share, Class A common stock $ 0.51 $ (0.27 ) $ 0.24 Weighted average shares outstanding of Class B common stock, basic and diluted 4,312,500 - 4,312,500 Basic and diluted net income per share, Class B common stock $ 0.51 $ (0.27 ) $ 0.24 For the Nine Months Ended September 30, 2022 (unaudited) As Previously Restatement As Restated Total operating expenses $ (3,053,747 ) $ - $ (3,053,747 ) Other income (expenses): Change in fair value of derivative warrant liabilities 5,929,000 - 5,929,000 Gain from extinguishment of deferred underwriting commissions allocated to derivative warrant liabilities 6,037,500 (5,749,511 ) 287,989 Interest earned on operating account 4 - 4 Income from investments held in Trust Account 281,713 - 281,713 Income before income tax expense 9,194,470 (5,749,511 ) 3,444,959 Income tax expense 8,022 - 8,022 Net income $ 9,186,448 $ (5,749,511 ) $ 3,436,937 Weighted average shares outstanding of Class A common stock, basic and diluted 11,246,592 - 11,246,592 Basic and diluted net income per share, Class A common stock $ 0.59 $ (0.37 ) $ 0.22 Weighted average shares outstanding of Class B common stock, basic and diluted 4,312,500 - 4,312,500 Basic and diluted net income per share, Class B common stock $ 0.59 $ (0.37 ) $ 0.22
Schedule of company’s previously reported statement of cash flows	For the Six Months Ended June 30, 2022 (unaudited) As Previously Restatement As Restated Net income $ 10,629,568 $ (5,749,511 ) $ 4,880,057 Adjustments to reconcile net income to net cash used in operating activities: Change in fair value of derivative warrant liabilities (5,929,000 ) - (5,929,000 ) Gain from extinguishment of deferred underwriting commissions allocated to derivative warrant liabilities (6,037,500 ) 5,749,511 (287,989 ) Income from investments held in Trust Account (224,219 ) - (224,219 ) Changes in operating assets and liabilities: Prepaid expenses 57,723 - 57,723 Accounts payable 258,731 - 258,731 Accrued expenses 1,041,731 - 1,041,731 Due to related party (29,311 ) - (29,311 ) Franchise tax payable (70,522 ) - (70,522 ) Income tax payable 6,535 - 6,535 Net cash used in operating activities $ (296,264 ) $ - $ (296,264 ) Supplemental disclosure of noncash financing activities: Extinguishment of deferred underwriting commissions allocated to Public Shares $ - $ 5,749,511 $ 5,749,511 For the Nine Months Ended September 30, 2022 (unaudited) As Previously Restatement As Restated Net income $ 9,186,448 $ (5,749,511 ) $ 3,436,937 Adjustments to reconcile net income to net cash used in operating activities: Change in fair value of derivative warrant liabilities (5,929,000 ) - (5,929,000 ) Gain from extinguishment of deferred underwriting commissions allocated to derivative warrant liabilities (6,037,500 ) 5,749,511 (287,989 ) Income from investments held in Trust Account (281,713 ) - (281,713 ) Changes in operating assets and liabilities: Prepaid expenses 75,099 - 75,099 Accounts payable 1,498,738 - 1,498,738 Accrued expenses 1,227,066 - 1,227,066 Due to related party (29,311 ) - (29,311 ) Franchise tax payable (20,111 ) - (20,111 ) Income tax payable 8,022 - 8,022 Net cash used in operating activities $ (302,262 ) $ - $ (302,262 ) Supplemental disclosure of noncash financing activities: Extinguishment of deferred underwriting commissions allocated to Public Shares $ - $ 5,749,511 $ 5,749,511

Basis of Presentation and Sum_2

Basis of Presentation and Summary of Significant Accounting Policies (Tables)	12 Months Ended
	Dec. 31, 2022
Description of Organization and Business Operations [Abstract]
Schedule of basic and diluted net loss per share	For the Years Ended December 31, 2022 2021 Class A Class B Class A Class B Basic and diluted net income per common stock: Numerator: Allocation of net income $ 4,388,957 $ 2,173,118 $ 4,438,620 $ 1,109,655 Denominator: Basic and diluted weighted average common stock outstanding 8,709,777 4,312,500 17,250,000 4,312,500 Basic and diluted net income per common stock $ 0.50 $ 0.50 $ 0.26 $ 0.26

Class A Common Stock Subject _2

Class A Common Stock Subject to Possible Redemption (Tables)	12 Months Ended
	Dec. 31, 2022
Class A Common Stock Subject to Possible Redemption [Abstract]
Schedule of class A common stock subject to possible redemption reflected on the balance sheet	Gross proceeds $ 172,500,000 Less: Fair value of Public Warrants at issuance (8,226,780 ) Offering costs allocated to Class A common stock subject to possible redemption (9,544,063 ) Plus: Accretion on Class A common stock subject to possible redemption amount 17,770,843 Class A common stock subject to possible redemption, December 31, 2021 172,500,000 Less: Redemption of Class A common stock subject to possible redemption (160,679,460 ) Adjustment for accretion of Class A common stock subject to possible redemption amount (5,749,511 ) Plus: Waiver of offering costs allocated to Class A common stock subject to possible redemption 5,749,511 Class A common stock subject to possible redemption, December 31, 2022 $ 11,820,540

Fair Value Measurements (Tables

Fair Value Measurements (Tables)	12 Months Ended
	Dec. 31, 2022
Fair Value Measurements [Abstract]
Schedule of financial assets and liabilities that are measured at fair value on a recurring basis	Description Quoted Significant Significant Liabilities Derivative warrant liabilities – Public $ 86,250 $ - $ - Derivative warrant liabilities – Private Placement $ - $ 48,500 $ - Description Quoted Significant Significant Assets: Investments held in Trust Account – U.S. Treasury securities $ 172,543,076 $ - $ - Liabilities: Derivative warrant liabilities – Public $ 4,226,250 $ - $ - Derivative warrant liabilities – Private Placement $ - $ - $ 2,376,500
Schedule of quantitative information regarding Level 3 fair value measurements inputs at their measurement dates	As of Exercise price $ 11.50 Unit price $ 10.15 Volatility 8.80 % Stock price $ 9.90 Expected life of the options to convert (years) 5.42 Risk-free rate 1.29 %
Schedule of changes in the fair value of the derivative warrant liabilities, measured using level 3 inputs	2022 2021 Derivative warrant liabilities as of January 1 $ 2,376,500 $ 14,580,610 Transfer out of Level 3, Public Warrants start trading - (5,354,620 ) Transfer of Private Placement Warrants to Level 2 (242,500 ) - Change in fair value of derivative warrant liabilities – Level 3 (2,134,000 ) (6,849,490 ) Derivative warrant liabilities as of December 31 – Level 3 $ - $ 2,376,500

Income Taxes (Tables)

Income Taxes (Tables)	12 Months Ended
	Dec. 31, 2022
Income Taxes [Abstract]
Schedule of income tax provision (benefit)	For the Years Ended 2022 2021 Current Federal $ 73,131 $ - State - - Deferred Federal (137,164 ) (510,213 ) State - - Valuation allowance 137,164 510,213 Income tax provision $ 73,131 $ -
Schedule of net deferred tax assets	December 31, 2022 2021 Deferred tax assets: Start-up/Organization costs $ 636,790 $ 499,627 Net operating loss carryforwards - 39,808 Total deferred tax assets 636,790 539,435 Valuation allowance (636,790 ) (539,435 ) Deferred tax asset, net of allowance $ - $ -
Schedule of reconciliation of the statutory federal income tax rate (benefit)	For the Years Ended 2022 2021 Statutory federal income tax rate 21.0 % 21.0 % Change in fair value of warrant liabilities -20.5 % -30.2 % Gain from extinguishment of deferred underwriting commissions allocated to derivative warrant liabilities -0.9 % 0.0 % Change in valuation allowance 2.1 % 9.2 % Income tax expense 1.7 % 0.0 %

Description of Organization a_2

Description of Organization and Business Operations (Details) - USD ($)					1 Months Ended			12 Months Ended
	Dec. 28, 2022	Jun. 16, 2022	Jun. 15, 2022	Jun. 14, 2022	Jan. 31, 2023	Aug. 16, 2022	Dec. 22, 2020	Dec. 31, 2022
Description of Organization and Business Operations (Details) [Line Items]
Generating proceeds							$ 172,500,000
Offering costs amount							10,000,000
Deferred underwriting commissions							$ 6,000,000
Special meeting of stockholders, description				In connection with the Special Meeting, stockholders holding 16,409,033 public shares exercised their right to redeem such shares for a pro rata portion of the funds held in the trust account, which would have resulted in (i) approximately $164.1 million (approximately $10.00 per share) being removed from the trust account to pay such holders, (ii) approximately $8.4 million remaining in the trust account and (iii) 5,153,467 shares of common stock outstanding (including 840,967 public shares and 4,312,500 Founder Shares (as defined in Note 5)).
Redemptions of public shares, description		On June 15 and 16, 2022, the Company consented to requests to reverse the redemptions of an aggregate of 341,087 public shares. As a result of such redemption reversals, (i) stockholders holding an aggregate of 16,067,946 public shares exercised and have not reversed their right to redeem such shares for a pro rata portion of the funds held in the trust account, (ii) approximately $160.7 million (approximately $10.00 per share) was removed from the trust account to pay such holders, (iii) approximately $11.8 million remained in the trust account and (iv) 5,494,554 shares of common stock remained outstanding (including 1,182,054 public shares and 4,312,500 Founder Shares).	On June 15 and 16, 2022, the Company consented to requests to reverse the redemptions of an aggregate of 341,087 public shares. As a result of such redemption reversals, (i) stockholders holding an aggregate of 16,067,946 public shares exercised and have not reversed their right to redeem such shares for a pro rata portion of the funds held in the trust account, (ii) approximately $160.7 million (approximately $10.00 per share) was removed from the trust account to pay such holders, (iii) approximately $11.8 million remained in the trust account and (iv) 5,494,554 shares of common stock remained outstanding (including 1,182,054 public shares and 4,312,500 Founder Shares).
Percentage of public shares								20%
Obligation to redeem percentage								100%
Interest to pay dissolution expenses								$ 100,000
Share price (in Dollars per share)								$ 10
Description of trust account								In order to protect the amounts held in the trust account, the Sponsor has agreed to be liable to the Company if and to the extent any claims by a third party (except for the Company’s independent registered public accounting firm) for services rendered or products sold to the Company, or a prospective target business with which the Company has entered into a letter of intent, confidentiality or other similar agreement or Business Combination agreement (a “Target”), reduce the amount of funds in the trust account to below the lesser of (i) $10.00 per public share and (ii) the actual amount per public share held in the trust account as of the date of the liquidation of the trust account, if less than $10.00 per public shares due to reductions in the value of the trust assets, less taxes payable, provided that such liability will not apply to any claims by a third party or Target that executed a waiver of any and all rights to the monies held in the trust account (whether or not such waiver is enforceable) nor will it apply to any claims under the Company’s indemnity of the underwriters of the initial public offering against certain liabilities, including liabilities under the Securities Act of 1933, as amended (the “Securities Act”).
Dividends common stock	$ 5,000,000
Cash in operating account								$ 300
Working capital deficit								1,700,000
Investment income								295,000
Loan proceeds from sponsor								$ 31,000
U.S.federal excise tax percentage						1%
Fair market value excise tax						1%
Initial Public Offering [Member]
Description of Organization and Business Operations (Details) [Line Items]
Number of units in shares (in Shares)							17,250,000
Public Shares [Member]
Description of Organization and Business Operations (Details) [Line Items]
Number of units in shares (in Shares)							2,250,000
Per unit price (in Dollars per share)								$ 10
Over-Allotment Option [Member]
Description of Organization and Business Operations (Details) [Line Items]
Number of units in shares (in Shares)							2,250,000	2,250,000
Per unit price (in Dollars per share)							$ 10
Private Placement Warrant [Member]
Description of Organization and Business Operations (Details) [Line Items]
Number of units in shares (in Shares)								4,850,000
Per unit price (in Dollars per share)								$ 1
Per unit price (in Dollars per share)								$ 1
Generating proceeds								$ 4,850,000
Sponsor [Member]
Description of Organization and Business Operations (Details) [Line Items]
Generating proceeds								$ 4,900,000
Private Placement [Member]
Description of Organization and Business Operations (Details) [Line Items]
Per unit price (in Dollars per share)								$ 10
Net proceeds								$ 172,500,000
Founder Shares [Member]
Description of Organization and Business Operations (Details) [Line Items]
Payment amount								$ 25,000
Subsequent Event [Member]
Description of Organization and Business Operations (Details) [Line Items]
Proceeds from settlement agreement					$ 2.75
Business Combination [Member]
Description of Organization and Business Operations (Details) [Line Items]
Owns or acquires, percentage								50%
Net tangible assets of business combination								$ 5,000,001
Business Combination [Member] | Initial Public Offering [Member]
Description of Organization and Business Operations (Details) [Line Items]
Owns or acquires, percentage								80%

Restatement of Previously Iss_3

Restatement of Previously Issued Financial Statements (Details) - Schedule of company’s previously reported statement of changes in stockholders’ deficit - USD ($)	6 Months Ended	9 Months Ended	12 Months Ended
	Jun. 30, 2022	Sep. 30, 2022	Dec. 31, 2022
Previously Reported [Member]
Accumulated Deficit:
Begining Balance	$ (14,309,985)	$ (14,309,985)	$ (14,309,985)
Net Income	10,629,568	9,186,448
Adjustment for accretion of Class A common stock subject to possible redemption amounts – accumulated deficit
Ending balance	(3,680,417)	(5,123,537)
Previously Reported [Member] | Accumulated Deficit [Member]
Accumulated Deficit:
Begining Balance	(14,309,985)	(14,309,985)	(14,309,985)
Net Income			3,937,702
Adjustment for accretion of Class A common stock subject to possible redemption amounts – accumulated deficit			5,749,511
Ending balance			(4,622,772)
Previously Reported [Member] | Total Stockholders’ Deficit [Member]
Accumulated Deficit:
Begining Balance	(14,309,554)	(14,309,554)	(14,309,554)
Net Income			3,937,702
Adjustment for accretion of Class A common stock subject to possible redemption amounts – accumulated deficit			5,749,511
Ending balance			(4,622,341)
Revision of Prior Period, Adjustment [Member]
Accumulated Deficit:
Begining Balance
Net Income	(5,749,511)	(5,749,511)
Adjustment for accretion of Class A common stock subject to possible redemption amounts – accumulated deficit		5,749,511
Ending balance
Revision of Prior Period, Adjustment [Member] | Accumulated Deficit [Member]
Accumulated Deficit:
Begining Balance
Net Income			2,624,373
Adjustment for accretion of Class A common stock subject to possible redemption amounts – accumulated deficit
Ending balance			2,624,373
Revision of Prior Period, Adjustment [Member] | Total Stockholders’ Deficit [Member]
Accumulated Deficit:
Begining Balance
Net Income			2,624,373
Adjustment for accretion of Class A common stock subject to possible redemption amounts – accumulated deficit
Ending balance			2,624,373
Restated [Member]
Accumulated Deficit:
Begining Balance	(14,309,985)	(14,309,985)	(14,309,985)
Net Income	4,880,057	3,436,937
Adjustment for accretion of Class A common stock subject to possible redemption amounts – accumulated deficit		5,749,511
Ending balance	(3,680,417)	(5,123,537)
Restated [Member] | Accumulated Deficit [Member]
Accumulated Deficit:
Begining Balance	(14,309,985)	(14,309,985)	(14,309,985)
Net Income			6,562,075
Adjustment for accretion of Class A common stock subject to possible redemption amounts – accumulated deficit			5,749,511
Ending balance			(1,998,399)
Restated [Member] | Total Stockholders’ Deficit [Member]
Accumulated Deficit:
Begining Balance	$ (14,309,554)	$ (14,309,554)	(14,309,554)
Net Income			6,562,075
Adjustment for accretion of Class A common stock subject to possible redemption amounts – accumulated deficit			5,749,511
Ending balance			$ (1,997,968)

Restatement of Previously Iss_4

Restatement of Previously Issued Financial Statements (Details) - Schedule of company’s previously reported statements of operations - USD ($)	3 Months Ended	6 Months Ended	9 Months Ended
	Jun. 30, 2022	Jun. 30, 2022	Sep. 30, 2022
As Previously Reported [Member]
Condensed Income Statements, Captions [Line Items]
Total operating expenses	$ (1,120,935)	$ (1,554,619)	$ (3,053,747)
Other income (expenses):
Change in fair value of derivative warrant liabilities	2,290,750	5,929,000	5,929,000
Gain from extinguishment of deferred underwriting commissions allocated to derivative warrant liabilities	6,037,500	6,037,500	6,037,500
Interest earned on operating account	1	3	4
Income from investments held in Trust Account	166,440	224,219	281,713
Income before income tax expense	7,373,756	10,636,103	9,194,470
Income tax expense	6,535	6,535	8,022
Net income	7,367,221	10,629,568	9,186,448
Restatement Adjustment [Member]
Condensed Income Statements, Captions [Line Items]
Total operating expenses
Other income (expenses):
Change in fair value of derivative warrant liabilities
Gain from extinguishment of deferred underwriting commissions allocated to derivative warrant liabilities	(5,749,511)	(5,749,511)	(5,749,511)
Interest earned on operating account
Income from investments held in Trust Account
Income before income tax expense	(5,749,511)	(5,749,511)	(5,749,511)
Income tax expense
Net income	(5,749,511)	(5,749,511)	(5,749,511)
As Restated [Member]
Condensed Income Statements, Captions [Line Items]
Total operating expenses	(1,120,935)	(1,554,619)	(3,053,747)
Other income (expenses):
Change in fair value of derivative warrant liabilities	2,290,750	5,929,000	5,929,000
Gain from extinguishment of deferred underwriting commissions allocated to derivative warrant liabilities	287,989	287,989	287,989
Interest earned on operating account	1	3	4
Income from investments held in Trust Account	166,440	224,219	281,713
Income before income tax expense	1,624,245	4,886,592	3,444,959
Income tax expense	6,535	6,535	8,022
Net income	$ 1,617,710	$ 4,880,057	$ 3,436,937
Class A Common Stock [Member] | As Previously Reported [Member]
Other income (expenses):
Weighted average shares outstanding of Class A common stock, basic and diluted (in Shares)	15,484,292	16,362,268	11,246,592
Basic and diluted net income per share, Class A common stock (in Dollars per share)	$ 0.37	$ 0.51	$ 0.59
Class A Common Stock [Member] | Restatement Adjustment [Member]
Other income (expenses):
Weighted average shares outstanding of Class A common stock, basic and diluted (in Shares)
Basic and diluted net income per share, Class A common stock (in Dollars per share)	$ (0.29)	$ (0.27)	$ (0.37)
Class A Common Stock [Member] | As Restated [Member]
Other income (expenses):
Weighted average shares outstanding of Class A common stock, basic and diluted (in Shares)	15,484,292	16,362,268	11,246,592
Basic and diluted net income per share, Class A common stock (in Dollars per share)	$ 0.08	$ 0.24	$ 0.22
Class A Common Stock [Member] | As Previously Reported [Member]
Other income (expenses):
Weighted average shares outstanding of Class B common stock, basic and diluted (in Shares)	4,312,500	4,312,500	4,312,500
Basic and diluted net income per share, Class B common stock (in Dollars per share)	$ 0.37	$ 0.51	$ 0.59
Class A Common Stock [Member] | Restatement Adjustment [Member]
Other income (expenses):
Weighted average shares outstanding of Class B common stock, basic and diluted (in Shares)
Basic and diluted net income per share, Class B common stock (in Dollars per share)	$ (0.29)	$ (0.27)	$ (0.37)
Class A Common Stock [Member] | As Restated [Member]
Other income (expenses):
Weighted average shares outstanding of Class B common stock, basic and diluted (in Shares)	4,312,500	4,312,500	4,312,500
Basic and diluted net income per share, Class B common stock (in Dollars per share)	$ 0.08	$ 0.24	$ 0.22

Restatement of Previously Iss_5

Restatement of Previously Issued Financial Statements (Details) - Schedule of company’s previously reported statement of cash flows - USD ($)	3 Months Ended	6 Months Ended	9 Months Ended
	Jun. 30, 2022	Jun. 30, 2022	Sep. 30, 2022
As Previously Reported [Member]
Condensed Cash Flow Statements, Captions [Line Items]
Net income		$ 10,629,568	$ 9,186,448
Adjustments to reconcile net income to net cash used in operating activities:
Change in fair value of derivative warrant liabilities		(5,929,000)	(5,929,000)
Gain from extinguishment of deferred underwriting commissions allocated to derivative warrant liabilities	$ (6,037,500)	(6,037,500)	(6,037,500)
Income from investments held in Trust Account		(224,219)	(281,713)
Changes in operating assets and liabilities:
Prepaid expenses		57,723	75,099
Accounts payable		258,731	1,498,738
Accrued expenses		1,041,731	1,227,066
Due to related party		(29,311)	(29,311)
Franchise tax payable		(70,522)	(20,111)
Income tax payable		6,535	8,022
Net cash used in operating activities		(296,264)	(302,262)
Supplemental disclosure of noncash financing activities:
Extinguishment of deferred underwriting commissions allocated to Public Shares
Restatement Adjustment [Member]
Condensed Cash Flow Statements, Captions [Line Items]
Net income		(5,749,511)	(5,749,511)
Adjustments to reconcile net income to net cash used in operating activities:
Change in fair value of derivative warrant liabilities
Gain from extinguishment of deferred underwriting commissions allocated to derivative warrant liabilities	5,749,511	5,749,511	5,749,511
Income from investments held in Trust Account
Changes in operating assets and liabilities:
Prepaid expenses
Accounts payable
Accrued expenses
Due to related party
Franchise tax payable
Income tax payable
Net cash used in operating activities
Supplemental disclosure of noncash financing activities:
Extinguishment of deferred underwriting commissions allocated to Public Shares		5,749,511	5,749,511
As Restated [Member]
Condensed Cash Flow Statements, Captions [Line Items]
Net income		4,880,057	3,436,937
Adjustments to reconcile net income to net cash used in operating activities:
Change in fair value of derivative warrant liabilities		(5,929,000)	(5,929,000)
Gain from extinguishment of deferred underwriting commissions allocated to derivative warrant liabilities	$ (287,989)	(287,989)	(287,989)
Income from investments held in Trust Account		(224,219)	(281,713)
Changes in operating assets and liabilities:
Prepaid expenses		57,723	75,099
Accounts payable		258,731	1,498,738
Accrued expenses		1,041,731	1,227,066
Due to related party		(29,311)	(29,311)
Franchise tax payable		(70,522)	(20,111)
Income tax payable		6,535	8,022
Net cash used in operating activities		(296,264)	(302,262)
Supplemental disclosure of noncash financing activities:
Extinguishment of deferred underwriting commissions allocated to Public Shares		$ 5,749,511	$ 5,749,511

Basis of Presentation and Sum_3

Basis of Presentation and Summary of Significant Accounting Policies (Details) - USD ($)	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Basis of Presentation and Summary of Significant Accounting Policies (Details) [Line Items]
Federal depository insurance coverage (in Dollars)	$ 250,000
Common stock subject to possible redemption	1,182,054
Aggregate shares issued	13,475,000
Class A Common Stock [Member]
Basis of Presentation and Summary of Significant Accounting Policies (Details) [Line Items]
Common stock subject to possible redemption		17,250,000

Basis of Presentation and Sum_4

Basis of Presentation and Summary of Significant Accounting Policies (Details) - Schedule of basic and diluted net loss per share - USD ($)	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Class A Common Stock [Member]
Numerator:
Allocation of net income	$ 4,388,957	$ 4,438,620
Denominator:
Basic and diluted weighted average common stock outstanding	8,709,777	17,250,000
Basic and diluted net income per common stock	$ 0.5	$ 0.26
Class B Common Stock [Member]
Numerator:
Allocation of net income	$ 2,173,118	$ 1,109,655
Denominator:
Basic and diluted weighted average common stock outstanding	4,312,500	4,312,500
Basic and diluted net income per common stock	$ 0.5	$ 0.26

Initial Public Offering (Detail

Initial Public Offering (Details) - $ / shares	1 Months Ended	12 Months Ended
	Dec. 22, 2020	Dec. 31, 2022
Initial Public Offering (Details) [Line Items]
Description of stock	Each unit consists of one share of Class A common stock and one-half of one redeemable warrant (each whole warrant, a “warrant”). Each whole warrant entitles the holder to purchase one share of Class A common stock at a price of $11.50 per share.
Initial Public Offering [Member]
Initial Public Offering (Details) [Line Items]
Number of units in shares	17,250,000
Additional purchase of units		2,250,000
Over-Allotment Option [Member]
Initial Public Offering (Details) [Line Items]
Number of units in shares	2,250,000	2,250,000
Unit per price (in Dollars per share)	$ 10

Related Party Transactions (Det

Related Party Transactions (Details) - USD ($)		1 Months Ended		12 Months Ended
	Jul. 10, 2020	Dec. 22, 2020	Dec. 17, 2020	Dec. 31, 2022	Dec. 31, 2021	Jun. 18, 2020
Related Party Transactions (Details) [Line Items]
Forfeited shares (in Shares)		562,500
Proceeds placed in trust account				$ 172,000,000
Expenses related to public offering						$ 200,000
Borrowing amount		$ 31,000
Working capital loans				1,500,000
Office space, secretarial and administrative services				10,000
Administrative services expenses				120,000	$ 120,000
Administrative services expenses				0	20,000
Due to related parties				$ 1,500	$ 30,811
Private Placement Warrants [Member]
Related Party Transactions (Details) [Line Items]
Number of shares (in Shares)				4,850,000
Share price (in Dollars per share)				$ 1
Generating proceeds				$ 4,850,000
Price per warrant (in Dollars per share)				$ 1
Founder Shares [Member]
Related Party Transactions (Details) [Line Items]
Number of shares (in Shares)	3,737,500
Common Stock, Par Value (in Dollars per share)	$ 0.0001
Aggregate price	$ 25,000
Founder shares outstanding (in Shares)			4,312,500
Forfeited shares (in Shares)			562,500
Percentage of shares issued and outstanding			20%
Class A Common Stock [Member] | Private Placement [Member]
Related Party Transactions (Details) [Line Items]
Price per share (in Dollars per share)				$ 11.5
Business Combination [Member]
Related Party Transactions (Details) [Line Items]
Business combination, description				The initial stockholders agreed, subject to limited exceptions, not to transfer, assign or sell any of the Founder Shares until the earlier to occur of (A) one year after the completion of the initial business combination or earlier if, subsequent to the initial business combination, the closing price of the Class A common stock equals or exceeds $12.00 per share (as adjusted for stock splits, stock capitalizations, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day period commencing at least 150 days after the initial business combination, and (B) the date following the completion of the initial business combination on which the Company completes a liquidation, merger, capital stock exchange or other similar transaction that results in all of the stockholders having the right to exchange their Class A common stock for cash, securities or other property.

Commitments and Contingencies (

Commitments and Contingencies (Details) - USD ($)			12 Months Ended
	Jun. 14, 2022	Dec. 22, 2020	Dec. 31, 2022
Commitments and Contingencies (Details) [Line Items]
Additional units issued (in Shares)		2,250,000
Underwriting discount		$ 3,450,000
Underwriting discount, per share (in Dollars per share)		$ 0.2
Deferred discount		$ 6,037,500
Deferred discount per share (in Dollars per share)		$ 0.35
Advisory fee	$ 3,800,000
Over-Allotment Option [Member]
Commitments and Contingencies (Details) [Line Items]
Additional units issued (in Shares)			2,250,000

Derivative Warrant Liabilities

Derivative Warrant Liabilities (Details) - shares	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Derivative Warrant Liabilities (Details) [Line Items]
Public warrants expiry term	5 years
Business combination, description	If (x) the Company issues additional shares of Class A common stock or equity-linked securities for capital raising purposes in connection with the closing of its initial business combination at an issue price or effective issue price of less than $9.20 per share of Class A common stock (with such issue price or effective issue price to be determined in good faith by the Company’s board of directors and, in the case of any such issuance to the initial stockholders or their affiliates, without taking into account any Founder Shares held by the initial stockholders or such affiliates, as applicable, prior to such issuance), (y) the aggregate gross proceeds from such issuances represent more than 60% of the total equity proceeds, and interest thereon, available for the funding of the initial business combination (net of redemptions), and (z) the volume weighted average trading price of the Class A common stock during the 20 trading day period starting on the trading day after the day on which the Company consummates the initial business combination (such price, the “Market Value”) is below $9.20 per share, the exercise price of the Warrants will be adjusted (to the nearest cent) to be equal to 115% of the higher of the Market Value and the Newly Issued Price, and the $18.00 per share redemption trigger price of the Warrants will be adjusted (to the nearest cent) to be equal to 180% of the higher of the Market Value and the Newly Issued Price.
Public warrants, description	The Company may call the Public Warrants for redemption:   ● in whole and not in part;   ● at a price of $0.01 per warrant;   ● upon a minimum of 30 days’ prior written notice of redemption; and   ● if, and only if, the last sales price of the Class A common stock equals or exceeds $18.00 per share on each of 20 trading days within the 30-trading day period ending on the third business day prior to the date on which the Company sends the notice of redemption to the warrant holders.
Public Warrants [Member]
Derivative Warrant Liabilities (Details) [Line Items]
Share issued	8,625,000
Private Placement Warrants [Member]
Derivative Warrant Liabilities (Details) [Line Items]
Share issued		4,850,000

Class A Common Stock Subject _3

Class A Common Stock Subject to Possible Redemption (Details) - $ / shares	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Class A Common Stock Subject to Possible Redemption (Details) [Line Items]
Common stock voting rights	Holders of the Company’s Class A common stock are entitled to one vote for each share.
Class A Common Stock [Member]
Class A Common Stock Subject to Possible Redemption (Details) [Line Items]
Ordinary shares, shares authorized	380,000,000	380,000,000
Ordinary shares, par value (in Dollars per share)	$ 0.0001	$ 0.0001
Common stock outstanding	1,182,054	17,250,000

Class A Common Stock Subject _4

Class A Common Stock Subject to Possible Redemption (Details) - Schedule of class A common stock subject to possible redemption reflected on the balance sheet - USD ($)	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Schedule of Class A Common Stock Subject To Possible Redemption Reflected On the Balance Sheet [Abstract]
Gross proceeds		$ 172,500,000
Less:
Fair value of Public Warrants at issuance		(8,226,780)
Offering costs allocated to Class A common stock subject to possible redemption		(9,544,063)
Plus:
Accretion on Class A common stock subject to possible redemption amount		17,770,843
Class A common stock subject to possible redemption	$ 11,820,540	$ 172,500,000
Less:
Redemption of Class A common stock subject to possible redemption	(160,679,460)
Adjustment for accretion of Class A common stock subject to possible redemption amount	(5,749,511)
Plus:
Waiver of offering costs allocated to Class A common stock subject to possible redemption	$ 5,749,511

Stockholders_ Deficit (Details)

Stockholders’ Deficit (Details) - $ / shares	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Stockholders’ Deficit (Details) [Line Items]
Preferred stock, shares authorized	1,000,000	1,000,000
Preferred stock, par value (in Dollars per share)	$ 0.0001	$ 0.0001
Common stock voting rights	Holders of the Company’s Class A common stock are entitled to one vote for each share.
Total number of shares percentage	20%
Class A Common Stock [Member]
Stockholders’ Deficit (Details) [Line Items]
Common stock, shares authorized	380,000,000	380,000,000
Common stock, par value (in Dollars per share)	$ 0.0001	$ 0.0001
Common stock subject to possible redemption shares outstanding	1,182,054	17,250,000
Common stock subject to possible redemption shares issued	1,182,054	17,250,000
Class B Common Stock [Member]
Stockholders’ Deficit (Details) [Line Items]
Common stock, shares authorized	20,000,000	20,000,000
Common stock, par value (in Dollars per share)	$ 0.0001	$ 0.0001
Common stock, shares issued	4,312,500	4,312,500
Common stock, shares outstanding	4,312,500	4,312,500
Common stock voting rights	Stockholders of record are entitled to one vote for each share held on all matters to be voted on by stockholders.

Fair Value Measurements (Detail

Fair Value Measurements (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Fair Value Measurements [Abstract]
Fair value of liabilities	$ 6.5	$ 8

Fair Value Measurements (Deta_2

Fair Value Measurements (Details) - Schedule of financial assets and liabilities that are measured at fair value on a recurring basis - USD ($)	Dec. 31, 2022	Dec. 31, 2021
Quoted Prices in Active Markets (Level 1) [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Derivative warrant liabilities – Public	$ 86,250	$ 4,226,250
Derivative warrant liabilities – Private Placement
Assets:
Investments held in Trust Account – U.S. Treasury securities		172,543,076
Significant Other Observable Inputs (Level 2) [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Derivative warrant liabilities – Public
Derivative warrant liabilities – Private Placement	48,500
Assets:
Investments held in Trust Account – U.S. Treasury securities
Significant Other Unobservable Inputs (Level 3) [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Derivative warrant liabilities – Public
Derivative warrant liabilities – Private Placement		2,376,500
Assets:
Investments held in Trust Account – U.S. Treasury securities

Fair Value Measurements (Deta_3

Fair Value Measurements (Details) - Schedule of quantitative information regarding Level 3 fair value measurements inputs at their measurement dates	12 Months Ended
	Dec. 31, 2021 $ / shares
Schedule of Quantitative Information Regarding Level 3 Fair Value Measurements Inputs At Their Measurement Dates [Abstract]
Exercise price	$ 11.5
Unit price	$ 10.15
Volatility	8.80%
Stock price	$ 9.9
Expected life of the options to convert (years)	5 years 5 months 1 day
Risk-free rate	1.29%

Fair Value Measurements (Deta_4

Fair Value Measurements (Details) - Schedule of changes in the fair value of the derivative warrant liabilities, measured using level 3 inputs - USD ($)	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Schedule of Changes in the Fair Value of the Derivative Warrant Liabilities, Measured Using Level 3 Inputs [Abstract]
Derivative warrant liabilities as of January 1	$ 2,376,500	$ 14,580,610
Transfer out of Level 3, Public Warrants start trading		(5,354,620)
Transfer of Private Placement Warrants to Level 2	(242,500)
Change in fair value of derivative warrant liabilities – Level 3	(2,134,000)	(6,849,490)
Derivative warrant liabilities as of December 31 – Level 3		$ 2,376,500

Income Taxes (Details)

Income Taxes (Details) - USD ($)	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Income Taxes [Abstract]
Valuation allowance	$0.6	$0.5
Operating loss carryovers	$ 0	$ 190,000

Income Taxes (Details) - Schedu

Income Taxes (Details) - Schedule of income tax provision (benefit) - USD ($)	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Current
Federal	$ 73,131
State
Deferred
Federal	(137,164)	(510,213)
State
Valuation allowance	137,164	510,213
Income tax provision	$ 73,131

Income Taxes (Details) - Sche_2

Income Taxes (Details) - Schedule of net deferred tax assets - USD ($)	Dec. 31, 2022	Dec. 31, 2021
Deferred tax assets:
Start-up/Organization costs	$ 636,790	$ 499,627
Net operating loss carryforwards		39,808
Total deferred tax assets	636,790	539,435
Valuation allowance	(636,790)	(539,435)
Deferred tax asset, net of allowance

Income Taxes (Details) - Sche_3

Income Taxes (Details) - Schedule of reconciliation of the statutory federal income tax rate (benefit)	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Schedule Of Reconciliation Of The Statutory Federal Income Tax Rate Benefit Abstract
Statutory federal income tax rate	21%	21%
Change in fair value of warrant liabilities	(20.50%)	(30.20%)
Gain from extinguishment of deferred underwriting commissions allocated to derivative warrant liabilities	(0.90%)	0%
Change in valuation allowance	2.10%	9.20%
Income tax expense	1.70%	0%